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1. Executive summary  
 
The so-called digital Polymerase Chain Reaction (dPCR) is a relatively new technique for the detection 
and quantification of DNA, but its application in analytical laboratories is steadily increasing. In 
contrast to quantitative real-time PCR, DNA (fragments) can be quantified here without the need for 
calibration curves. Using dPCR, the PCR mix containing the (target) DNA is partitioned – depending 
on the device used – currently into a maximum of 10,000,000 small compartments with a volume as 
low as a few picolitres. These can be either physically distinct compartments on a chip (referred to as 
chamber-based digital PCR [cdPCR]), or the compartments correspond to water-in-oil droplets 
(referred to as droplet digital [ddPCR]). Once the PCR has been carried out simultaneously in all 
compartments/droplets, it is common to both approaches that the number of positive and negative 
signals for each partition is counted by a fluorescence measurement.  
With this technique, an absolute quantification of DNA copy numbers can be performed with high 
precision and trueness, even for very low DNA copy numbers. Furthermore, dPCR is considered less 
susceptible than qPCR to PCR inhibitory substances that could be co-extracted during DNA extraction 
from different samples. 
Digital PCR has already been applied in various fields, for example for the detection and 
quantification of GMOs, species (animals, plants), human disease bioindicators, food viruses and 
bacteria including pathogens. 
When establishing dPCR in a laboratory, different aspects have to be considered. These include, but 
are not limited to, the adjustment of the type of the PCR master mix used, optimised primer and 
probe concentrations and the signal separation of positive and negative compartments. This 
document addresses these and other aspects and provides recommendations for the transfer of 
existing real-time PCR methods into a dPCR format. 
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2. Working group overview 
2.1 Working group establishment 
The Working Group (WG) on digital PCR was established based on a mandate adopted at the 28th 
meeting of the ENGL (European Network of GMO Laboratories) Steering Committee on 11th February 
2015. The WG was chaired by Sven Pecoraro, Bavarian Health and Food Safety Authority (LGL), 
Oberschleissheim, Germany. 
The other members of the Working Group were: Gilbert Berben, Walloon agricultural Research 
Center (CRA-W), Belgium; Malcolm Burns, LGC, United Kingdom; Philippe Corbisier, European 
Commission, Directorate-General Joint Research Centre (DG JRC), Belgium; Marzia De Giacomo, 
Italian Institute of Health (ISS), Italy; Marc De Loose, Flanders research institute for agriculture, 
fisheries and food (ILVO), Belgium; Emilie Dagand, Federal Office of Consumer Protection and Food 
Safety (BVL), Germany; David Dobnik, National Institute of Biology (NIB), Slovenia; Ronnie Eriksson, 
National Food Agency (NFA), Sweden; Arne Holst-Jensen, Norwegian Veterinary Institute (NVI), 
Norway; Dafni-Maria Kagkli, European Commission, Directorate-General Joint Research Centre (DG 
JRC), Italy; Joachim Kreysa, European Commission, Directorate-General Joint Research Centre (DG 
JRC), Belgium; Antoon Lievens, European Commission, Directorate-General Joint Research Centre 
(DG JRC), Belgium; Dietrich Mäde, State Institute for Consumer Protection Department of Food 
Safety Saxony-Anhalt (LAV ST), Germany; Marco Mazzara, European Commission, Directorate-
General Joint Research Centre (DG JRC), Italy; Annalisa Paternò, Istituto Zooprofilattico Sperimentale 
del Lazio e della Toscana- M. Aleandri (IZSLT), Italy; Verena Peterseil, Austrian Agency for Health and 
Food Safety (AGES), Austria; Christian Savini, European Commission, Directorate-General Joint 
Research Centre (DG JRC), Italy; Tereza Sovová, Crop Research Institute (CRI), Czech Republic; 
Slawomir Sowa, Plant Breeding and Acclimatization Institute (IHAR) - National Research Institute, 
Poland; Bjørn Spilsberg, Norwegian Veterinary Institute (NVI), Norway. 
2.2 Background 
Digital PCR (dPCR), in its different formats (chamber dPCR, droplet dPCR), is a rapidly evolving 
technology in the area of DNA analysis. Digital PCR brings various advantages over traditional real-
time PCR, including the large number of parallel repetitions (from a few hundred to thousands per 
sample), the potential to conduct absolute quantification without standard curves, and the reduced 
sensitivity to PCR inhibitors affecting DNA analysis. 
During 2014, the ENGL discussed the current application of dPCR to GMO analysis and identified that 
the technology had the potential to advance DNA analysis applied in a regulatory context. 
Advantages and disadvantages were identified during an ENGL discussion day where experts also 
identified some issues to be resolved to facilitate routine application of dPCR for DNA analysis.  
2.3 Mandate and tasks 
As part of the mandate from the ENGL Steering Committee, the WG was asked to review the 
following issues, identify future needs and propose approaches to address these: 
 
 Transferability of existing real-time PCR methods into a dPCR format; 
 Accreditation (including in-house validation); 
 Applicability to difficult matrices; 
 Applicability to analytical areas other than GM food/feed; 
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 Definition and assessment of relevant method performance criteria; 
 Multiplexing; 
 Summary of technical needs and requirements for implementing and applying dPCR. 
As a result, the following document was elaborated, addressing the various issues discussed and 
summarising relevant existing experience with dPCR, with the aim of helping laboratories to decide if 
dPCR will meet their specific needs. 
2.4 Scope 
The scope of the document is two-fold: firstly, the potential of the dPCR technologies present on the 
market and a comparison with real-time PCR are discussed. Furthermore, the different fields of 
application of dPCR are reflected upon. Secondly, it addresses technical issues, which are of 
relevance to laboratories using the dPCR technology or considering implementing it, and the scope 
includes issues linked to the method verification and implementation process. In addition, 
performance parameters relevant to the dPCR are discussed. 
3. Glossary  
 
- CB : confidence bounds  
- cdPCR : chamber digital PCR 
- CNV : copy number variation  
- ddPCR : droplet digital PCR 
- dMIQE : minimum information for publication of quantitative digital PCR experiments  
- DNA : deoxyribonucleic acid 
- dPCR : digital PCR 
- ENGL : European Network of GMO Laboratories 
- EURL GMFF : European Union Reference Laboratory for GM Food & Feed 
- GM event : a specific genetic modification (often used as synonym of GMO) 
- GM(O) : genetically modified (organism) 
- HGE : haploid genome equivalent 
- ISO : International Organization of Standardization 
- LC/MS : liquid chromatography/mass spectrometry 
- LOD : limit of detection 
- LOQ : limit of quantification 
- MPR : minimum performance requirements 
- MRPL : minimum required performance limit 
- NGS : next generation sequencing 
- PAL : precautionary allergen labelling 
- PCR : polymerase chain reaction 
- qMIQE : minimum information for publication of quantitative PCR experiments 
- qPCR : quantitative real-time PCR 
- RS : resolution of a digital assay 
- RSD : relative standard deviation 
- RSDr: repeatability standard deviation 
- RT-PCR : reverse transcription-polymerase chain reaction  
- UGM : unauthorised GMO 
- WG : working group 
- WG DIR : ENGL working group on 'Detection, Interpretation and Reporting on the presence of 
authorised and unauthorised genetically modified materials' 
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4. Introduction and description of technologies 
4.1 Introduction 
Methods for nucleic acid analysis that are already established and used on a routine basis include the 
Polymerase Chain Reaction (PCR). PCR came into common use in the 1980s due to the availability of 
the thermostable Taq DNA polymerase, and this allowed for unprecedented amplification and 
detection of specific DNA sequences. The amplified DNA was often visualized by staining, for example 
using ethidium bromide on an agarose gel, or by using capillary electrophoresis in a closed and 
automated instrument. Whilst end-point PCR was a very useful and flexible tool for the detection of 
specific DNA targets, its main limitation was its qualitative nature (limited to assessing presence or 
absence but not quantification of the target). 
Quantitative real-time PCR (qPCR) allows analysis of the kinetics of the amplification reaction 
(Higuchi et al., 1992) through monitoring in real-time a fluorescent signal which is directly 
proportional to the amount of DNA target sequence being generated during PCR amplification. The 
signal is produced either by fluorescent probes (Rasmussen et al., 1998) or by fluorescent 
intercalating reagents (Morrison et al., 1998). Quantification (i.e. determination of the amount of 
target copies present expressed as an absolute number) can be achieved during the exponential 
growth phase of the PCR, provided that an appropriate calibration curve based on standards of 
known analyte concentration is included in the PCR setup. Relative quantification, i.e. change relative 
to a reference, can also be achieved and does not require use of standard curves. Moreover, the 
added selectivity and specificity attributed to the reaction by the presence of the probe makes qPCR 
one of the most reliable methods and endorses it as the main method used for nucleic acid 
identification and quantification.  
Real-time PCR can suffer from a number of issues including:  
 Initial amplification cycles are assumed to be exponential but in practice this may not be the 
case;  
 Low initial concentrations of nucleic acid molecules may not amplify to detectable levels due 
to the presence of inhibitors; and  
 Quantification is relative to a calibration curve (PCR amplification efficiency in a sample of 
interest may be different from that of reference samples due to matrix differences).  
Some of these issues can be minimised or even mitigated entirely using digital PCR (dPCR). 
 
Digital PCR is also based on PCR, but the main difference from qPCR is the fact that the reaction 
volume is split over a high number of small partitions (from 500 up to millions) of a very small volume 
(currently from 6 nanoliters down to a few picoliters). After the PCR, each partition is scored either as 
positive or negative (binary or digital read-out). Statistical analysis of the results is then used to 
determine the absolute quantity of target DNA in a sample. The approach was first developed in 
1999 (Vogelstein and Kinzler, 1999) as a tool for cancer diagnostics, and the underlying principle is 
well developed in the fields of chemistry and physics, as well as in microbiology where the related 
most probable number (MPN) method is used to estimate the concentration of specific 
microorganisms in a matrix (Oblinger and Koburger 1975). 
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In dPCR, the distribution of target DNA templates throughout the partitions is assumed to follow a 
Poisson process. Based on counting the total number of positive and negative partitions and using 
Poisson statistics, the absolute number of DNA copies in the original sample can therefore be 
estimated (see 4. of this document for a more detailed statistical background). 
An example is illustrated in Figure 1. It should be stressed, however, that estimating the number of 
targets based on a Poisson (or binomial) distribution is based on the following series of assumptions: 
 Target molecules are randomly distributed over the total number of partitions under 
analysis; 
 Presence of the target leads to a positive classification of the partition; 
 Absence of the target leads to a negative classification of the partition; 
 All partitions have the same volume; 
 For absolute quantification the volume of the partitions should be known precisely (as the 
correctness of the measurement depends also on the accuracy with which the partition 
volume has been determined)  
 
 
  
9 
 
 
Figure 1 :  Examples of the results of dPCR runs. The top picture shows an example of the visual output on a Fluidigm dPCR 
device (cdPCR). The plate (chip) contains 765 partitions, i.e. chambers, of which 208 are shown as positive. The bottom 
diagram shows an example of the visual output on a Bio-Rad QX200 platform (ddPCR). The reaction contains up to 20,000 
droplets, and positive droplets have a higher fluorescence than negative droplets (In the example shown, there are 14,534 
droplets in total, of which 2,375 are positive).  
Digital PCR possesses a number of advantages compared to conventional endpoint PCR and qPCR: 
 The major advantage of the dPCR method is that it permits absolute target quantification 
without reference to a calibration curve. As a consequence, any matrix differences between 
calibrant and test sample that may cause different PCR amplification efficiencies are 
minimised; 
 Because of the very high level of sample partitioning achieved (through the high number of 
individual partitions), dPCR can produce results with very high precision (Hindson et al., 
2011); 
 Digital PCR may be ideally suited for the detection of minority targets in a high background of 
competing non-target DNA because in each partition containing the target, the ratio 
between target and non-target DNA is significantly higher than in the original sample; 
 Digital PCR amplification (and consequently the results) are less affected by partial inhibition 
(Rački et al., 2014b; Nixon et al., 2014; Iwobi et al. 2016). 
 
There are a number of dPCR instruments currently on the market providing evidence of the 
importance of this relatively new technology for quantitative molecular biology approaches. Digital 
PCR instruments currently available include "closed" (Fluidigm BioMark, Formulatrix Constellation) or 
"open" (Thermo Fisher Quant Studio 3D) chamber-based dPCR instruments (for details refer to Basu, 
2017) and water-in-oil emulsion droplet-based digital PCR (ddPCR; e.g. Bio-Rad/Bio-Rad: QX, 
RainDance: RainDrop, Stilla Technologies: Naica System). Future and next generation dPCR devices 
may include centrifugal devices and sliding microarray devices. 
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Currently, there are two main approaches for conducting dPCR: chamber-based methods and 
droplet-based methods. 
4.1.1 Chamber-based methods 
Chamber-based methods use pre-made solid-state partitions (chambers) into which the reaction 
mixture is injected. As with qPCR 96-well plates, the chambers are non-reusable plastic consumables. 
A dedicated thermal cycler allows the chambers to be cycled and read. The number and size of 
chambers per device is fixed and thus highly consistent over runs. The number of partitions and 
reactions per run is often lower than in droplet-based platforms.  
4.1.2 Droplet-based methods 
In ddPCR, the compartmentalization of the reaction mix is achieved by making a water-in-oil 
emulsion prior to the PCR - generation of high numbers of droplets. The DNA targets in the emulsion 
are amplified either in standard PCR wells, in strips or on plates and a dedicated reader measures the 
end-point fluorescence of the droplets. The number of partitions varies between different platforms 
and between individual reactions. 
4.2 Fields of application 
Apart from the analysis of Genetically Modified Organisms (GMOs), dPCR has broad applicability 
across a number of sectors. These include:  
 Food fraud and food authenticity testing in general (e.g. meat speciation and quantitation; 
Floren et al., 2015);  
 Prenatal diagnostics (e.g. aneuploidy and testing for Down’s syndrome; Evans et al., 2012);  
 Cancer diagnostics (trace detection for a minority target, where early detection means faster 
treatment and greater chance of successful recovery; Ma et al., 2013);  
 Viral and bacterial load measurements (important in monitoring and diagnosis of infectious 
diseases, for example influenza and Mycobacterium tuberculosis; Sedlak and Jerome, 2013; 
and  
 Testing for antimicrobial resistance and harmful micro-organisms (Whale et al., 2016b).  
 
In the following paragraphs, we give a short overview of how dPCR can be applied in these fields. 
4.2.1 Application of dPCR in the field of GMO detection and quantification 
 GMO detection and quantification – general considerations 
For many plant species, e.g. maize, rapeseed, rice and soybean, there are multiple GM events. For 
GMO detection and quantification, it is common to relate the GM target to a species specific 
reference target. The reference target can serve multiple functions. The primary function of the 
reference gene is to inform the analyst of the presence of a particular species (ingredient). 
Furthermore, if quantified, it can:  
 Provide an estimate of the amount of species DNA that is extracted from the sample;  
 Provide data on the amount of the species DNA that is necessary if the analyst wishes to 
quantify the GMO content relative to the species; 
 Allow the analyst to determine the practical limit of detection (LOD) and the practical limit of 
quantification (LOQ) of GM events of the species in question in the sample.  
With multiple GM events belonging to the same species, there are several approaches to cost-
efficient detection and quantification. Many of the GM events have been transformed using the 
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same or related genetic constructs resulting in identical or very similar sequences of the inserts of 
these GMOs. This has been exploited in many routine laboratories applying the so-called element 
screening (or the matrix approach) for GMO detection as discussed broadly in e.g. Holst-Jensen et al. 
(2012). However, in some cases it may be necessary to help supplement this approach with 
additional event-specific methods in order to facilitate full coverage of all authorised GM events for a 
particular species. The results of the screening can be matched against a reference matrix (listing 
presence/absence data for specific screening markers in all known GMOs). Correspondence between 
the observed presence/absence patterns and the presence/absence patterns of specific GMOs in the 
reference matrix suggest possible presence of the specific GMOs in the tested product. Absence of 
signals for certain elements is indicative evidence of the absence of specific GMOs in the tested 
products (at the LOD). This information can then be used to select more specific PCRs (construct and 
event specific real-time PCRs) for identification and quantification. Element screening can be done 
using real-time PCR or end-point PCR and may be multiplexed. 
An alternative screening strategy would be to use (multiplex) event specific approaches. These can 
be strictly qualitative or (semi-)quantitative. Published examples include both qPCR and dPCR 
approaches (e.g. Querci et al., 2009; Kluga et al., 2011; Gerdes et al., 2012; Kim et al., 2010; Košir et 
al., 2017a). The use, including both descriptions and recommendations, is discussed in further detail 
in annex A. 1. 
The use of qPCR for cost-efficient GMO detection is challenged by the large and increasing number of 
GMOs on the market (including both authorized and un-authorized events). This is a problem 
because firstly each quantification with qPCR requires a standard curve of high quality. Secondly, due 
to the fact that in case of the detection and quantification of several GM-events per species (e.g. 
soybean) all these quantitative analytical results (per GM-event) sometimes need to be added (e.g. in 
order to evaluate correct food or feed labelling) and as a result the overall RSD (relative standard 
deviation) is the combination of all RSDs (as root of summed squares). This can be a problem because 
quantification is imprecise and difficult at near LOQ concentrations. Thirdly, PCR inhibitors co-
extracted with sample DNA can cause a problem because the inhibitors can result in other 
amplification efficiencies than those observed for the standard curves, thus affecting the reliability of 
quantitative data. Fortunately, dPCR offers solutions to all these three major challenges.  
Application of dPCR in GMO detection 
With minor modifications, any probe-based qPCR assay can be converted into a dPCR assay. Many 
species-, element- and event-specific qPCR assays have been validated in a collaborative trial and are 
in current use in GMO-laboratories around the world. The EURL GMFF is maintaining a database of 
these qPCR assays (GMOMETHODS: EU Database of Reference Methods for GMO Analysis) and the 
ENGL members have a long history and experience with their use and know their strengths and 
weaknesses.  
Notably, in contrast to qPCR, no standard curve is needed for dPCR in GMO quantification. This is 
because absolute DNA copy quantification performed with dPCR is inherently quantitative. When 
applied for one (or multiple) transgene(s) as well as for the reference gene (species specific), the 
GMO quantity relative to the reference gene can be calculated. Furthermore, partitioning increases 
the ratio of low concentration targets relative to non-target DNA. As a consequence, competitive 
exclusion of low concentration targets by high concentration targets is thus generally not a problem 
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in dPCR. PCR inhibitors affect the amplification efficiency, but only exceptionally lead to complete 
inhibition of the amplification reaction. For qPCR, however, partial inhibition would reduce 
amplification efficiency and consequently delay the accumulation of fluorescent signal, leading to 
underestimation of the target concentration. For dPCR partial inhibition is not a problem as long as 
the presence of a template copy in a partition yields a positive amplification signal detectable at the 
end-point. 
Simplex dPCR for GMO detection 
Most official quantitative detection methods published by the EURL GMFF are so far based on qPCR 
with hydrolysis probes (European Reference Laboratory for GM Food & Feed Status of dossiers; 
http://gmo-crl.jrc.ec.europa.eu/StatusOfDossiers.aspx). Several laboratories have tested the 
potential of dPCR in a chamber-based (cdPCR) or in droplet-based (ddPCR) format for the analysis of 
GMO. The ratio of absolute copy numbers of transgene per reference gene determined by cdPCR was 
found to be identical to the ratio measured by real-time quantitative PCR (qPCR) using a plasmid DNA 
calibrator. These results indicate that both methods could be applied to determine the copy number 
ratio of MON810 maize (Corbisier et al., 2010). Well characterised certified reference material 
bearing one copy of the transgenic target and one copy of the species reference target have been 
used to verify several assumptions of dPCR, some of which relate to Poisson statistics. The 
assumptions are (i) a large number of PCR reactions are analysed, as with most statistics a larger 
number of replicates/partitions means more power to discriminate small differences (Pagano and 
Gauvreau, 2000), (ii) random distribution of target DNA (Pinheiro et al., 2012), (iii) independent 
segregation of target DNA (Bhat et al., 2009), (iv) that every partition containing one or more DNA 
copies gives a signal and (v) that every molecule is double stranded DNA (Bhat et al. 2010). The 
absolute LOD and LOQ of cdPCR for GM quantification has been reported (Burns et al., 2010) and the 
applicability of ddPCR for routine analysis in food and feed samples has been demonstrated with the 
quantification of GMO (Morisset et al., 2013). Finally, the contribution of several assay parameters 
(singleplex/duplex ddPCR, assay volume, thermal cycler, probe manufacturer, oligonucleotide 
concentration, annealing/elongation temperature and a droplet separation evaluation) have been 
evaluated for the quantification of GMO by ddPCR (Gerdes et al., 2016). 
The optimisation of DNA concentration in GMO quantification by dPCR around GM contents of 0.1 % 
is recommended. Detailed explanations are provided in annex A. 2 to generally illustrate such 
"lambda optimised approach". 
Multiplexing of dPCR in GMO detection 
While absolute quantification is often used (and needed) in other fields, GMOs are usually quantified 
relative to a species. When GMOs are quantified, dPCR offers an approach that qPCR cannot provide. 
For instance a duplex dPCR, where the species and the GMO of that same species are separately 
detected, e.g. with two separate fluorescence, will potentially yield the relative GMO concentration 
directly. 
Many dPCR instruments currently available have two different fluorescent channels. Multiplexing 
therefore is limited compared to qPCR devices with multiple (e.g. five) channels. Duplex dPCR 
methods are conceptually similar to duplex qPCR methods and several methods to quantify one GM-
specific target and one reference gene have been published (Morriset et al., 2013; Gerdes et al., 
2016; Dalmira et al., 2016). A triplex assay can be achieved on a two channel (e.g. FAM/VIC) 
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instrument by labelling one probe with FAM, a second probe with VIC and for the third target a 1:1 
mixture of FAM and VIC labelled probes (Pretto et al., 2015; Dobnik et al., 2016; Whale et al., 2016a). 
By analysing single labelled and double labelled partitions the three targets can be distinguished in a 
probe-mixing assay (Whale et al., 2016a; also refer to 4.3.6). 
 
By using different concentrations of probes (i.e. 100 and 300 nM) two targets can be distinguished 
based on absolute endpoint fluorescence read in the same channel (Dobnik et al., 2016), (4.3.6, 
Figure 5). Four levels of fluorescence will be expected, negative, single positive for each target and 
double positives. This strategy can be extended to analyse four targets in two channels using high 
and low probe concentrations in each channel. This approach was applied using a method covering 
seven maize events (MON863, MON810, DP98140, MIR604, GA21, MON89034 and MIR162) and a 
maize reference gene (hmgA) in two assays. In a 2-D plot of fluorescence for two fluorescence 
channels, a total of 16 clusters of partitions can be expected (4.3.6, Figure 6). (Note: For the sake of 
quality assurance, this kind of analysis should be computerized and not performed on spreadsheets.) 
Dobnik et al. (2016) developed a computer-script to do automated threshold setting and 
quantification based on the various clusters.  
The threshold for labelling of GM products in the EU (i.e. 0.9 % according to Regulation (EC) No 
1829/2003) refers to the concentration(s) of EU authorized GMO(s) per ingredient (species). 
Although not (yet) common in EU enforcement laboratories, this theoretically opens the possibility to 
measure EU-authorized events of each single species together in one fluorescence channel and a 
species-specific reference gene in another fluorescence channel. This approach of multiplexing of 
dPCR in GMO analysis has successfully been demonstrated for EU-authorized GM maize (Dobnik et 
al., 2015) and GM soybean (Košir et al., 2017a). The latter study also included all soybean events 
falling under Regulation (EU) No. 619/2011 (at the time of publishing). Such methods will report the 
sum of a set of events (e.g. all EU authorised events) from one species (without taking stacked events 
into account). Alternative applications are also possible, e.g. by using dPCR multiplex for screening 
purposes and by subsequently re-analysing (quantitatively) only such samples, estimated to contain 
> 0.9 % GM material by singleplex or duplex dPCR (or qPCR) for the events detected.  
The main advantage of duplex and multiplex dPCR assays are cost efficiency, due to the fact that 
multiple standard curves are not needed. In addition, for assays where the GM target(s) and the 
reference gene are analysed in the same partition (droplet or chamber), possible pipetting errors are 
reduced when relative concentrations are calculated.  
Additional notes regarding practical aspects of multiplex dPCR are given in annex A. 3.  
4.2.2 Digital PCR applications for monitoring human disease states 
Digital PCR is ideally suited for identification of minor amounts of DNA targets such as point 
mutations, chromosomal translocations, DNA methylation and alternatively spliced mRNA. This has 
found applications in areas such as cancer diagnostics, non-invasive prenatal diagnostics, and 
assessment of microbial resistance. Additionally, dPCR can be used for the quantification of viral load 
(Trypsteen et al., 2016; Sedlak and Jerome, 2013).  
Digital PCR can also be used to measure and monitor copy number variations (CNV) which arise when 
an individual has one or more deletions/duplications of a particular genomic region (Usher and 
McCaroll, 2015) . CNV can occur naturally, but in humans, it can be used as an indication of disease 
state, for example as in aneuploidy (e.g. Down's syndrome) and cancer diagnosis (e.g. HER2 tumour 
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cell amplification in breast cancer). Current methods for measuring CNV include karyotyping, use of 
arrays, immunohistochemistry, PCR and Next Generation Sequencing (NGS). However, dPCR may 
provide a more rapid method for identifying CNV compared to traditional methods. Digital PCR can 
measure more accurately smaller fold changes than traditional qPCR, and therefore can be used for 
prenatal screening and tumour screening applications, as well as detection of CNV in cell-free DNA. 
Digital PCR is helpful for prenatal diagnostics without the need for invasive approaches, for example 
by sampling cell-free foetal DNA from the maternal blood plasma (non-invasive prenatal testing, 
NIPT) (Lo et al., 2007; Zimmermann et al., 2008; Fan et al., 2009). 
4.2.3 Digital PCR applications in the field of food virology 
Hepatitis A virus (HAV) and norovirus (NoV) are important agents of food-borne human viral 
illnesses. No routine methods exist to culture these viruses from food matrices. Detection is 
therefore reliant on molecular methods using the reverse transcription-polymerase chain reaction 
(RT-PCR) followed by qPCR. Coudray-Meunier et al. (2015) published a comparative study of dPCR 
and qPCR for quantification of Hepatitis A virus and Norovirus in lettuce and water samples. For 
certain food matrices, e.g. bivalve shellfish, quantitative analysis is considered necessary for risk 
analysis. Quantification of levels of virus RNA by conventional real-time RT-PCR has been described in 
ISO 15216-1:2017. Due to the complexity of the method, it is necessary to include a comprehensive 
suite of controls, which need to be quantified as well. In the ISO standard mentioned, dPCR can be 
used as an option to quantify the nucleic acid control material. 
The virus load of any sample can be estimated using dPCR. Preliminary data have shown that RT-PCR 
inhibitors do not have the same severe impact on quantitative data in dPCR compared to 
conventional real-time RT-PCR (Rački et al., 2014b). In principle, dPCR should allow quantification of 
any virus. Determination of virus loads is a prerequisite to estimate the risk connected to a certain 
food item and to verify the effectiveness of preventive measures, either at technological or at 
epidemiological level. A possible field of application besides HAV and NoV could be the detection of 
Hepatitis-E-virus in liver sausages, which is closely linked to food safety. 
4.2.4 Digital PCR in the agricultural and environmental field 
The fields of agricultural and environmental testing may be considered distinct but also share several 
similarities and to some degree overlap. They typically include a broad range of target organisms and 
complex matrices and the presence of inhibitory substances can be a great challenge (Strand et al., 
2011; Rački et al., 2014b). The quantification of plant and animal pathogens is gaining importance, as 
regulatory bodies are shifting toward quantitative microbial risk assessments instead of mere 
qualitative detection. 
Real-time PCR is used for water monitoring and microbial source identification with faecal indicator 
bacteria, plant, animal and human pathogens (Boben et al., 2007; Strand et al., 2011 and 2014; 
Huang et al., 2016; Masago et al., 2016; Wang et al., 2016) and invasive species (Doi et al., 2015). 
However, these assays are subject to bias introduced by reliance on quantitative standards, difficulty 
in multiplexing and inhibition. Digital PCR has shown to reduce all these problems and has proven to 
be appropriate in monitoring, faecal source identification and detection of pathogenic and invasive 
species in water samples (Morisset et al., 2013; Rački et al., 2014a; Doi et al., 2015; Cao et al., 2015). 
Plant material, soil, and wastewater are matrices known to have high levels of inhibitors that reduce 
the likelihood of detecting and quantifying targets of interest (e.g. plant pathogens). Analyses with 
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dPCR have a higher resilience to inhibitors commonly found in such samples, in contrast to qPCR 
(Rački et al., 2014b). 
4.2.5 Digital PCR applications in the field of species identification 
Identification of species, including plants, animals or microorganisms, is important in order to be able 
to monitor food integrity and to detect food fraud. However, monitoring the compliance of the 
relevant EU labelling legislation by demonstrating the presence or absence of a particular species or 
products derived thereof, is also highly important. Species identification is important to define the 
origin and traceability of raw materials and derived food products as well as to check for the 
potential unintentional occurrence of other species (contamination). The most extensive use of 
molecular techniques (genomic and proteomic techniques) is for determination of species and 
botanical origin, while all other techniques are mostly dealing with adulteration and geographical 
origin (Danezis et al., 2016). In some cases, such as food allergens, it is also a food safety issue (EU 
Regulation 1169/2011). Finally in the context of protection of endangered species, detection and 
identification of organisms is essential too (Staats et al., 2016 and references therein). 
The adventitious presence of traces of species in the food supply chain often cannot be avoided 
completely. For food allergens and endangered species, the presence of even minute quantities may 
be unacceptable. Quantification based on determination of species DNA copy numbers is an 
attractive approach to meet these needs. The application of dPCR in this evolving field will most likely 
facilitate implementation of cost-effective and reliable analyses in the near future (Scollo et al., 
2016). In the context of food allergens, one should distinguish between 
a) checking compliance with the legislation on the labelling of ingredients, and  
b) checking the accidental presence/contamination of foods with allergens.  
The latter, precautionary allergen labelling principle (PAL), is voluntary and currently not required by 
any legal act in the EU (at the time of publication). Digital PCR might be a very interesting tool for 
checking for compliance of product composition with its corresponding ingredient list and for 
searching for other, potentially unintended components. Conversion factors are needed in order to 
be able to compare such results with results obtained by analytical methods detecting other target 
molecules. The use of dPCR to checking for accidental presence of food allergens should probably be 
implemented primarily as a screening tool that needs to be complemented with LC/MS methods. 
4.2.6 Digital PCR applications in the field of microbiology 
In Europe, thermophilic Campylobacter are one of the major bacterial food pathogens (EFSA & ECDC 
2015). Hygienic measures in the whole food chain, starting at primary production, are considered as 
the most effective tool to fight campylobacteriosis. Risk assessment in slaughterhouses is based on 
Campylobacter quantification by conventional microbiology. This methodology, however, is prone to 
underestimation of the infectious bacterial contamination because “viable but non cultivable” 
Campylobacter are not detected. This problem also affects several other foodborne pathogens. 
Qualitative molecular methods are available and standardized (ISO/TS 13136:2012; ISO/TS 
18867:2015). The application of dPCR may provide a step towards quantification in this important 
field. 
Several food-borne bacterial pathogens such as Bacillus cereus, Staphylococcus aureus, and 
Clostridium perfringens owe their pathogenicity to the production of toxins after multiplication. 
Several toxigenic fungi such as Aspergillus, Fusarium and Penicillium spp. also affect food safety. As 
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the detection of toxins in food can be cumbersome in routine testing, an attractive alternative is the 
use of microbial counts as rough estimates for the food safety. The microbial counts, however, are 
not strictly related to toxin production. Not all strains are toxigenic, and the toxin production can also 
vary among strains and with environmental conditions. Some toxins produced by foodborne 
pathogens (bacteria and fungi) can be persistent to processing methods like heating, irradiation or 
high pressure that kill the microorganisms (e.g. trichothecene mycotoxins produced by Fusarium 
spp., enterotoxins produced by Staphylococcus aureus, and emetic toxin produced by Bacillus cereus; 
Stenfors Arnesen et al., 2008; Pinchuk et al., 2010; Hennekinne et al., 2012; EMAN, 2015). Thus, the 
toxins may be present also in the absence of viable pathogens. DNA is also relatively persistent to 
such treatment. Thus, DNA based detection/quantification may be very useful to assess the potential 
presence of toxins. The advantages listed above for dPCR compared to qPCR suggest that dPCR may 
also prove superior to qPCR for the enumeration of foodborne pathogens. 
In microbiology, dPCR has been applied ‒ besides bacteria, viruses and fungi ‒ to parasite analysis, 
e.g. for the sensitive detection and identification of parasites from human blood (Wilson et al., 2015). 
5. Technical aspects of digital PCR 
This part of the document goes into more detail on each technical aspect of dPCR, giving background 
and guidelines on each facet of the GMO analytical chain. Extra attention is devoted to differences 
from the standard qPCR approach. 
This part of the document is subdivided into six modules, each representing a step in the analytical 
process from sample preparation and analysis to results generation and their interpretation. The six 
sections are: 
1. Theoretical basis of dPCR; 
2. DNA extraction; 
3. PCR; 
4. Results and performance requirements; 
5. Data interpretation and reporting; 
6. MIQE guidelines for publishing dPCR data. 
 
5.1 Theoretical basis of digital PCR 
5.1.1 Statistics and assumptions 
Central to the analysis of dPCR is the Poisson distribution, a discrete probability distribution that 
expresses the probability of a given number of events1 occurring in a fixed interval of time or space. It 
assumes that these events occur with a (fixed) average rate and independently of time since the last 
event. The Poisson distribution is given by: 
𝑃(𝑘) = (𝑒−) ∗
𝑘
𝑘!
 
 
(1) 
                                                          
1
 Event is a statistical term and does not refer to GM event in this paragraph 
  
17 
 
Where 𝑃(𝑘) is the probability to observe exactly 𝑘 targets (e.g. molecules),  is the average number 
of events per interval and 𝑘 is the actual number of events. In the context of dPCR, the event is 
"presence of the target sequence" and  is the average number of targets per partition. 
Analysis of dPCR results is based on the assumption that the distribution of the target sequence over 
the partitions is a nearly perfect Poisson process. Let ntot be the total number of partitions for which 
we have a read-out and nneg the number of negative partitions, we then estimate p0 (probability of an 
empty partition) and  (the average number of targets per partition) as: 
𝑝0 =
𝑛𝑛𝑒𝑔
𝑛𝑡𝑜𝑡
 (2) 
 
 = −ln 𝑝0 (3) 
The ratio of GMO in the sample (in haploid genome equivalents) is then given by 
𝑅𝑎𝑡𝑖𝑜 =  
𝑡𝑟
𝑒𝑛
 (4) 
Where tr and en are the concentration estimates for the transgene and endogene, respectively. 
Note that calculating the GM ratio does not require the droplet volume to be known, it is however 
assumed to be constant. This assumption, however, is not absolutely correct (Dong et al., 2015). 
Variability in the droplet volume will increase the quantification uncertainty. Most manufacturers 
have taken precautions to keep this variability within strict limits (e.g. excessively large or small 
droplets may be removed from analysis). The 95 % confidence bounds (CB) can be calculated for each 
of the individual  estimates: 
𝑒𝑛,  𝐶𝐵 =  𝑒𝑛  ±  1.96 √
𝑛𝑡𝑜𝑡 − 𝑛𝑛𝑒𝑔
𝑛𝑡𝑜𝑡 ∗ 𝑛𝑛𝑒𝑔
 (5) 
 
𝑡𝑟,  𝐶𝐵 =  𝑡𝑟  ±  1.96 √
𝑛𝑡𝑜𝑡 − 𝑛𝑛𝑒𝑔
𝑛𝑡𝑜𝑡 ∗ 𝑛𝑡𝑛𝑒𝑔
 (6) 
Whereas the CB for the ratio of transgene to endogene is obtained using Fieller´s theorem: 
𝑅𝑎𝑡𝑖𝑜𝐶𝐵 =  
𝑡𝑟 𝑒𝑛 ±  √𝑡𝑟
2  𝑒𝑛
2 − (𝐸2 −  𝑒𝑛
2 )(𝑇2 −  𝑡𝑟
2 ) 
𝑡𝑟
2 − 𝑇2
 
(7) 
Where  
𝐸 =  |𝑒𝑛 −  𝑒𝑛,   𝐶𝐵| (8) and 𝑇 =  |𝑡𝑟 −  𝑡𝑟,   𝐶𝐵|        (9) 
with CB being the relevant confidence bound (upper or lower). Where 𝐸 is the absolute difference 
between the concentrates estimates of the endogenous target and the confidence bound associated 
to that estimation and 𝑇 is the absolute difference between the concentrate estimates of the 
transgenic target and the confidence bound associated to that estimation. 
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As an alternative to Fieller’s theorem, an ad hoc confidence interval can be used (ratio ± 1.96 ∗ 
standard deviation of the ratio). Such a confidence interval is more straightforward to calculate and 
has been shown to have 95 % coverage when a sufficient number or repeats is used to obtain the 
standard deviation of the ratio (e.g. four repeats: two subsamples analysed in duplicate; see Lievens 
et al., 2016).  
5.2 DNA extraction 
Methodologies for investigating the quality of the extracted DNA to be analysed in qPCR have been 
extensively described. Related acceptance criteria have been elaborated with particular focus on 
applications for GMO detection (Marchesi et al., 2015). The number of references about this topic in 
relation to dPCR is still limited, but some experimental evidence indicate that dPCR is less sensitive to 
PCR inhibition compared to qPCR (Nixon et al., 2014; Rački et al., 2014b; Iwobi et al., 2016). As target 
concentration in dPCR is calculated from endpoint positive and negative reactions, one can assume 
that partial PCR inhibition will have less impact on quantification. Generally, the same DNA quality 
requirements should be applied to dPCR analysis as for qPCR analysis. 
There are many methods for extraction of DNA that will yield high quality DNA, i.e. non-degraded 
and free of excess salts, proteins or polysaccharides (e.g. Murray and Thompson, 1980; Sambrook 
and Russel, 2001). In addition, DNA quality also depends on sample processing that affects structural 
integrity and physical-chemical purity of the extracted DNA.  
5.2.1 Sample preparation 
Concerning sample preparation there are no specific requirements for dPCR, one can therefore refer 
to the document developed within the ENGL: Guidelines for sample preparation procedures in GMO 
analysis (Berben et al., 2014). 
5.2.2 DNA yield 
Regarding the quantity and concentration of extracted DNA, no special requirements are 
recommended for dPCR. The yield should be at least as much as is required for the subsequent PCR 
analyses (Marchesi et al., 2015). 
5.2.3 DNA structural integrity  
With regard to structural integrity, considering that the amplicon length of dPCR systems is identical 
to their qPCR counterparts, the effects of DNA fragmentation are expected to be the same for all PCR 
systems. 
Under certain circumstances, it may be necessary to perform a restriction digest of the DNA before 
partitioning in droplets or chambers to improve the accuracy of the measurement for the following 
reasons: 
 
a) Decreasing the viscosity of the DNA solution;  
Hindson et al. (2011) reported changes of droplet volume and possible decrease of accuracy of 
measurement when using more than 66 ng DNA (human genomic DNA) in a 20 µL ddPCR due to 
increased viscosity of the DNA solution. By restriction digest this viscosity could be reduced and even 
much higher DNA concentrations (1 µg) could be used in ddPCR without affecting the droplet 
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volume. BioRad recommends restriction digestion whenever DNA input is greater than 66 ng per 20 
µL reaction (Kaihara et al., 2016). 
 
b) Separation of linked gene copies; 
If the DNA molecules contain linked gene copies (e.g. tandem gene copies) one positive droplet or 
partition will contain multiple copies (e.g. two linked copies will be counted as one copy). This can be 
overcome by restriction digest which leads to a physical separation of such gene copies (BioRad 
Bulletin 6277 Rev A, 2012) and thus enables independent segregation. 
 
c) Improving the accessibility of the DNA when working with supercoiled plasmids; 
By linearisation of plasmid DNA by restriction digest the accessibility (and thus the efficiency of 
primer/probe binding to the DNA) can be improved, leading to more accurate quantification of the 
plasmid (Kaihara et al., 2016); 
 
If a restriction digest of DNA is performed prior to dPCR there are three considerations that should 
be taken into account in the choice of enzyme for a particular locus: 
(1) The enzyme should not cut within the PCR amplicon sequence itself; 
(2) It is best to use an enzyme that is insensitive to methylation to avoid incomplete 
fragmentation due to methylation of the target DNA; and 
(3) In some instances, it is optimal to digest the target copy to the smallest size fragment that 
fully contains the amplicon footprint [sequence] – preferable under a few hundred base pairs 
(BioRad Bulletin 6277 Rev A, 2012). 
Often restriction enzymes with 4-base and 6-base recognition sites are used. 
However based on practical experience restriction digest of DNA is not mandatory and should be 
considered on a case-by-case decision (Jacchia et al., 2018).  
Note: Random shearing (fragmentation) of the DNA by sonication and a column-based method has 
been reported to improve the accuracy of measurement in analysing mitochondrial DNA (Vitomirov 
et al., 2017). 
5.2.4 Purity of DNA extracts 
With regard to physical-chemical purity of the DNA extract, PCR (and in particular qPCR) is known to 
be susceptible to inhibition due to the possible presence of impurities in the extracted DNA (Huggett 
et al., 2008; Kennedy and Oswald, 2011). Notwithstanding the still limited experience, dPCR is 
demonstrated to be less prone to inhibition (Nixon et al., 2014; Rački et al.; 2014b; Iwobi et al., 
2016). Until there is sufficient evidence to conclude otherwise, acceptance criteria already set for 
qPCR are considered valid also for dPCR. 
5.2.5 Additional recommendations 
Some methods for DNA extraction might interfere with droplet generation. The impact of the 
extraction method on downstream workflow should therefore be evaluated once in the process of 
implementing dPCR in a laboratory. This can be done by extracting a) a certified reference material, 
and b) a food sample, with the standard DNA extraction methods applied in a specific laboratory. 
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Two DNA dilutions should be tested each for a) and b). The droplet plots between DNA extraction 
methods should be compared in terms of signal (positive and negative droplets) separation and 
signal intensity. If an extraction method shows significantly deviating (poor) performance compared 
to others, then this method should not be used for extraction of DNA for dPCR. 
 
Another important consideration is whether the DNA subjected to analysis is double or (partially) 
single stranded when partitioned. The different strands of fully denatured molecules may be divided 
over different partitions, leading to two positives for a single (double stranded) target copy. As a 
consequence, if a significant portion of the sample DNA is denatured, the amount of target will be 
overestimated if the user assumes that only double-stranded DNA is quantified. This effect can occur, 
when DNA is exposed to sustained elevated temperatures or alkaline solution which therefore should 
be considered and avoided when designing dPCR experiments for absolute quantification of DNA 
copy numbers (Bhat et al., 2011).  
The options are to either validate the method that produces 100 % of single stranded DNA and then 
apply a 2-fold factor to concentration calculations or to validate a method that produces 100 % of 
double stranded DNA (Holden et al., 2009 ) 
Another important assumption is that the DNA target molecules segregate independently. If the DNA 
molecules are concatemers or physically bound to each other, one positive droplet or partition would 
contain multiple copies (e.g. two linked copies will be counted as one copy).  
5.3 PCR  
The set-up of a dPCR follows very closely the assembly of a qPCR. The reaction ingredients include: 
template nucleic acid, forward and reverse primers, a hydrolysis probe (e.g. TaqMan, not included for 
detection strategies using intercalating dye), sterile nuclease-free water to adjust the reaction 
volume, and the master mix. The latter includes the reaction buffer, bivalent cations, nucleotides, 
and a DNA polymerase (plus the DNA intercalating dye  e.g. SYBR® Green or EvaGreen  if this 
detection strategy is selected). In addition, technical additives may be included, depending on the 
master mix and the digital PCR format. 
The main difference from qPCR is the step of partitioning the reaction mix into a large number of 
chambers or droplets which typically occurs shortly before the amplification itself. 
5.3.1 Master mix 
In cdPCR, a loading reagent is added to the reaction mix to facilitate the microfluidics of the 
partitioning. In droplet-based systems, specific surfactants are often included in the master mix in 
order to add stability to the droplets and to minimize coalescence once they are formed. 
As a consequence, proprietary master mixes associated with specific platforms are commonly used 
for dPCR and the use of other non-proprietary master mixes is not recommended by the instrument 
manufacturers. However, a few instrument platforms (e.g. Constellation, Naica, and Raindance 
systems) are not bound to the use of dedicated master mixes. At least for Constellation, the master 
mix used should contain ROX dye.  
The JRC method database (GMOMETHODS) contains protocol information for more than a hundred 
validated GMO assays. The large majority of these make use of some type of commercial master mix 
optimized for qPCR. Protocols already validated for qPCR may need to be amended when used with 
another master mix.  
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Commercial master mixes may include non-declared components that can yield false positives. For 
example, the presence of bovine serum albumin (BSA) may yield positive signals for a dPCR targeting 
bovine. Special attention should therefore always be given to unexpected results for negative 
controls when modifying a qPCR protocol for dPCR application. 
In the case of GMO methods, this can be done by evaluating the specificity of the detection method 
for the taxon and for the GM target, taking into account the following aspects:  
 
Composition of the master mix. While the exact composition of master mixes is generally not 
known, the concentrations of the key components is usually stated (MgCl2, dNTPs, polymerase, 
buffer). If their concentrations are comparable (within 10 % variation) with the conditions of the 
validated conditions (master mix), then the reassessment of specificity is not required. Otherwise, an 
experimental check on selected targets is recommended (Onori et al., in preparation). It is advisable 
to select and check those targets, which have the most sequence similarities (primer and probe 
sequences) compared to the method to be implemented. This can be done by bioinformatic analyses 
using e.g. the molecular database CCSIS (Central Core DNA Sequence Information System) of the 
EURL GMFF or one of the NCBI databases (National Center for Biotechnology Information). 
5.3.2 Primers and probe concentrations 
For the design and selection of primers and probes, one should use the same rules as for qPCR assays 
(in terms of target-matching, base composition, length, melting temperature, absence of secondary 
structures and self- and inter-complementarity and specificity (Degen et al., 2006) ). However, 
primers and probe concentrations in dPCR are usually higher than in qPCR. Higher primer and probe 
concentrations increase the intensity of the end-point fluorescence signal and thus allow better 
separation of the background noise from specific signals, aiding more accurate quantification of the 
target. Tests carried out in ddPCR (BioRad QX200) on twelve assays validated by the EURL GMFF in 
qPCR have shown that the best results were obtained when the final concentration of primers were 
set around 500 nM per reaction while keeping the primer:probe ratio the same as the validated 
qPCR conditions (Lievens et al., 2016).  
 
Manufacturers may recommend certain combinations of reporter and quencher. For instance, in the 
Bio-Rad QX200 ddPCR system, it is recommended to NOT use TAMRA as a quencher as its emission 
overlaps with the emission of HEX (or VIC®), resulting in additional background signals in the second 
fluorescence channel. This deteriorates cluster separation and peak resolution. Instead, the use of 
non-fluorescent quenchers is recommended. Nevertheless, this relates not only to dPCR but can be 
considered as a general recommendation as TAMRA contributes to an overall increase in 
fluorescence background. Changing the fluorescent dye or quencher during the transfer from qPCR 
to dPCR should generally not have any effect on the performance, thus additional validation is not 
needed, unless the change affects the annealing temperature of the probe (e.g. MGB probes). In such 
case additional optimisation and validation are necessary. 
For the transfer of existing qPCR methods into a dPCR format, it is recommended to initially use the 
concentrations from the validated qPCR method, and to run a primer/probe concentration gradient if 
it is deemed necessary to improve the end-point fluorescence values of the positive partitions.  
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Primer and/or probe concentrations. If primer/probe concentrations are (substantially) changed, 
additional performance parameters should be experimentally assessed (e.g. specificity and trueness, 
Hougs et al., 2017). 
 
Primer and/or probe sequence. In case of changing of primer/probe sequence, a full validation of 
such a new method is needed. For method performance parameters, see e.g. Marchesi et al., 2015 
5.3.3 Temperature cycling program 
In general, the temperature profile used in qPCR can be directly applied to dPCR. However, one 
should always check the manufacturer's recommendations for specific requirements. For example, in 
droplet-based systems, a final step at higher temperature (e.g. 98 °C, 10 min for the Bio-Rad 
QX100/200 ddPCR systems) may be mandatory to further stabilize the droplets prior to reading 
them. There may also be recommendations concerning the ramping rate to ensure uniform heating 
of the partitions (droplet or chamber).  
It is also advisable to run a minimum of 45 amplification cycles, in order to have sufficient separation 
between positive signals and background noise. An example is illustrated in Figure 2.  
a) 
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b) 
 
 
Figure 2: Signal separation in cdPCR for MON 810 (Primers 300 nM, Probe 180 nM) performed with QuantStudio™ 3D 
Digital PCR System either run with 39 (a) or 45 (b) PCR cycles. 
Annealing temperature. The annealing temperature contributes to the specificity of PCR reactions, 
and it should ideally be maintained in line with that of validated methods. However, in the case of co-
amplification of a secondary target (multiple clouds of positive droplets) one can increase the 
annealing temperature in order to have sufficient separation between positive signals and 
background noise (Figure 3). If the deviation in temperature falls within the robustness range 
[assessed for the validated method], there is no (general) need for specificity testing. Nevertheless 
the specificity should be tested with a method whose annealing temperature is decreased. If the 
annealing temperature of a method is increased, it is not necessary to test the specificity because the 
new conditions are more stringent for primer annealing (Onori et al.; in preparation). 
Possible effects of different annealing temperatures on signal (positives) to background (negatives) 
separation is illustrated in Example 2, Figure 4. 
Example 1: Acp1 co-amplification of a secondary target  
Figure 3 below shows an annealing temperature gradient experiment with the same amplification 
system acp1 – acyl carrier protein, specific to cotton. This gene is present in two almost identical 
copies in cotton. One target has a perfect match to the designed PCR method while the other one 
contains four SNPs. The dPCR was run at temperatures ranging from 62 °C to 56 °C. While at the 
highest annealing temperature, the acp1 cloud is visible (blue dots, where each dot represents the 
fluorescent signal of one droplet) in addition to the background fluorescence (grey dots), at 
decreasing annealing temperatures a second cluster of positive droplets (grey dots above the Ch1 
amplitude of 3,000) stems from the co-amplification of the closely related gene at lower efficiency. 
As the annealing temperature lowers, its fluorescence gradually increases and gets closer to the acp1 
specific cluster of droplets. The highly stringent annealing temperature conditions at which the 
reaction was run at 62 °C impeded the amplification of the secondary target. 
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Figure 3 .  Annealing temperature gradient of the cotton-specific acp1 amplification system in ddPCR. As the annealing 
temperature is raised the specificity of the reaction increases and efficiency of the co-amplification is reduced, until the 
undesired droplet population merges with the negative population. 
Example 2: Temperature dependent signal separation of a lectin and MON 87769 soy-specific 
duplex ddPCR  
Figure 4 below shows an annealing temperature gradient experiment – using a 100 % MON 87769 
soy certified reference material – with a lectin and MON 87769 soy-specific duplex ddPCR, run at 
temperatures ranging from 66 °C to 56.3 °C. With decreasing annealing temperature, signal 
separation (positives and negatives for both lectin and MON 87769 reaction) increases to finally 
reach a maximum separation plateau. This increased separation reflects a more efficient primer and 
probe binding to the target DNA. Even at temperatures significantly below the validated 60 °C 
annealing temperature, no unspecific signal populations are observed. 
 
a) Lectin specific reaction: 
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b) MON 87769 specific reaction: 
 
 
 
Figure 4 .  Annealing temperature gradient of the lectin (a) and MON 87769 (b) soy-specific amplification system run in 
duplex ddPCR with a 100 % MON 87769 soy certified reference material. Purple numbers reflect calculated DNA copy 
numbers per microliter PCR reaction. Purple lines represent the threshold set for separating positive from negative droplet 
populations. 
5.3.4 The use of control samples 
Although quantification with dPCR is not dependent upon the generation of a calibration curve for 
results interpretation, it still requires the use of appropriate positive controls to provide evidence 
that the experiment has worked correctly. In addition, negative controls should always be used in a 
dPCR experiment to test for false positives. The use of control samples is essential for dPCR to 
control the appearance of the above-mentioned effects. In the case of routine GMO quantification, 
as for the qPCR, the controls described in ISO 24276 should also be used in dPCR. When an assay is 
being transferred from qPCR to dPCR, additional control samples should be used (e.g. certified 
reference material or samples with known GM content), enabling a direct evaluation of dPCR 
performance. 
5.3.5 Plasticware 
It appears that the brand of the plasticware and especially that of the tips can be of importance to 
reach good results. Due to the nature of the instruments, reactions should be set up in plasticware 
appropriate for use with digital PCR instruments according to the manufacturer´s recommendations. 
5.3.6 Considerations for multiplexing 
Multiplexing allows for simultaneous identification and quantification of more than one target in a 
single reaction. The majority of dPCR systems currently on the market can detect fluorescence in two 
colour channels, FAM and HEX (VIC®), and some have an option of detecting a third fluorophore. 
Duplex reactions can easily be implemented; fluorophore-specific signal is acquired through either 
channel, computed by the software algorithm and graphically represented in a two-axis plot of FAM 
and HEX amplitude. 
Although the availability of only two-colour channels (FAM and HEX) limits the choice of the 
reporters for TaqMan probes, more complex levels of multiplexing can be attained in dPCR by 
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labelling two or more probes, belonging to different target-specific assays, with the same reporter 
and varying the concentration of the probes (see Figures 5 and 6 for examples; also see Whale et al., 
2016a). This results in a spatial separation of the respective clusters of amplified targets on the basis 
of their florescence level. Identification of the clusters with their specific assays is established in 
simplex reactions during the optimisation stage of the test where the positioning of each cluster with 
the adjusted probe concentration can be easily identified in the two-dimensional plot. It is possible to 
successfully combine dPCR assays into multiplex assays if different reporter fluorophores (e.g. FAM 
and HEX) and probe concentrations are used for different targets. This, however, requires careful 
optimisation, and the complexity increases exponentially with the number of included targets. 
Separating the different targets into clearly identifiable clusters is necessary for reliable identification 
and quantification. Such multiplexing is theoretically possible with any dPCR format, but has so far 
only been demonstrated with ddPCR (time of publication). 
 
Figure 5: Example of duplex droplet readout in one fluorescence channel for three wells (one well for sample NTC and two 
wells for sample MON863 maize). Both probes (for hmgA and MON863) were labelled with the same fluorophore (FAM), 
but in the reaction mixture for hmgA the concentration was 100 nM for the probe and 300 nM for the primers (low), 
whereas for MON863 the concentration was 300 nM for the probe and 900 nM for the primers (high). In the 1D amplitude 
view, the positive droplets for the low primer/probe concentration target (hmgA) appear as cluster just above the negative 
one. The next cluster (above the hmgA cluster) are droplets positive for the high primer/probe concentration target 
MON863, whereas the topmost cluster are droplets positive for both of the targets. To achieve the best possible separation 
optimization of primer and probe concentrations is needed (Dobnik et al., 2016). 
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Figure 6: Graphical representation of possible target combinations in droplet clusters and their area of appearance in the 2-
D amplitude view. When primer and probe concentrations have been optimized for the best separation of clusters in 
individual channels, the assays may be combined to achieve the highest level of multiplexing (4-plex). In case of four targets 
(A, B, C and D), theoretically there are sixteen different possible clusters where the different combinations of targets might 
appear after readout. Presence or absence of the clusters depends on the ratio of targets in the sample and their initial 
concentration (Dobnik et al., 2016). 
The Regulation (EC) No 1829/2003 specifies that quantification of GM material shall be based on the 
concentration per ingredient (not per event). In practise, the ingredient is interpreted as species. 
Consequently, for the EU-authorised GMOs testing for legal compliance can be done  although not 
common practice in EU enforcement laboratories  using duplex (multiplex) quantification where the 
species specific reference gene is quantified in one channel and the authorised GMOs belonging to 
that same species are quantified simultaneously in the other channel, as exemplified for maize 
(Dobnik et al., 2015) and soybean (Košir et al., 2017a). 
5.4 Results and performance requirements 
Digital PCR is still only a PCR in a different format; thus all of the pre-written minimum performance 
requirements (MPRs) (Marchesi et al., 2015) also apply in this field, with the exception of 
amplification efficiency that is not as important because dPCR is an end-point reaction. Digital PCR 
assays must therefore be compliant  where appropriate  with these MPRs in order to be suitable 
as a method for quantification of GMOs. They should be valid not only for GMO detection methods, 
but for all applications of dPCR as they are technical criteria in order to ensure that the method 
works properly before proceeding towards determination of parameters such as LOD. 
Nevertheless, dPCR has some of its own specific issues which require setting some additional 
performance requirements, which must be fulfilled before proceeding to validation. If the PCR assay 
is specific and efficient, the main source of error in digital quantification is caused by the 
misclassification of partitions. To allow accurate classification of partitions and thus reliable 
quantification the method should meet acceptance levels within several criteria associated with the 
following simplex dPCR results: (I) single amplification product (there should only be two 
fluorescence populations), (II) peak resolution (as a measure of the separation between positives and 
negatives), and (III) the amount of stragglers or 'rain' (i.e. droplets that have an intermediate 
fluorescence and do not seem to belong to either the positive or negative population). Two further 
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criteria that apply to each reaction (post run evaluation) are: (IV) target concentration and (V) 
fraction of sample compartmentalized. In the following sections, we will define these specific criteria 
and set their limits, most of which are based on the qPCR MPR stating that the relative error should 
be below or equal to 25 %.  
In the course of method validation for the measurement of the dPCR-specific performance (e.g. 
resolution, amount of rain), it is recommended to select a target concentration, which would give the 
λ value around 0.7. This corresponds to a situation in which approximately half of the partitions are 
positive and thus allows gauging both the rain and the dispersion of the droplets without being 
biased by the fact that one population is larger than the other. 
Classification of partitions as positive or negative is based on the threshold, which should be set just 
above the cluster of negative partitions. NTC sample, with only negative partitions, can help in 
setting the threshold, however, an inspection of all wells/panels is recommended. Fluorescence 
amplitude of individual wells/panels might be slightly higher or lower than NTCs, thus in such cases 
the threshold can be adjusted individually to avoid misclassification of some droplets. 
A reaction is considered positive, when the number of positive partitions exceeds 2. There is no clear 
consensus on this value, however, this proposed value was determined based on experiments with a 
statistically significant replication level negative samples (0 % GM Material and NTCs, Dobnik et al., 
2015) and corresponds to the theoretical limit of detection of PCR. 
5.4.1 Amplification product of a single target 
In a qPCR reaction, the fluorescence measured is the sum of all amplification processes in the 
reaction mixture. It is therefore impossible to distinguish between different amplification products 
arising from the same primer probe combinations in the same reaction (e.g. the amplification of 
closely related sequences). In dPCR, the compartmentalisation allows such a distinction. Unintended 
amplification products (i.e. non-perfect match) usually amplify at a lower efficiency. This results in an 
endpoint fluorescence that is lower than for the actual target (after a standard run of 45 cycles). As a 
consequence, these amplifications show up in dPCR as an additional (distinct) population of droplets 
with fluorescence values between negatives and the true positive (see Figure 7 and Example 1, Figure 
3). The presence of multiple populations of droplets may complicate the digital analysis, affect the 
separation of positives from negatives, and ultimately lead to misclassification of droplets. Therefore, 
dPCR methods for GMO quantification should only amplify a single target unless the aim is to 
perform multiplexing. 
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Figure 7:  Illustration of multiple fluorescence populations. Panel A shows the results for the acp1 target, an additional 
population of fluorescence measurements is visible with values closely situated to the negatives. Panel B shows the results 
for the cruciferin (cruA) target, an additional population of fluorescence measurements is visible with values closely 
situated to the positives. Contrary to "rain", this kind of intermediate fluorescence is not uniformly spread between 
negatives and true positives, but appears in a more discrete manner. 
5.4.2 Amount of rain  
In many dPCR reactions there are partitions that seemingly fail to belong to either the positive or 
negative population. These partitions have an intermediate fluorescence level and are colloquially 
referred to as "rain" or "drag" (e.g. see Figures 3 and 4). Rain represents droplets with intermediate 
fluorescence that defy straightforward classification as either positive or negative. In contrast to 
unintended amplification products, rain does not seem to have a pronounced distribution but it is 
often equally spread between positives and negatives. The occurrence of rain may for example be 
attributed to a late PCR onset due to partial inhibition in a certain amount of droplets (Dreo et al., 
2014 and Dingle et al., 2013). In addition, experiments indicate that after a standard reaction (40 or 
45 cycles) the cloud of negatives may still house a population of rain partitions that have not yet had 
the time to accumulate fluorescence above the baseline level. Thus, the main question relating to 
how much rain we can tolerate becomes: how many rain partitions are "hiding" in the negative cloud 
(and are thus always misclassified). 
In order to set a limit to the amount of rain that can be allowed in dPCR reactions, we consider the 
misclassification of partitions. Simulation experiments show that, at the 1 % quantification level, 
approximately 2.5 % rain (percentage of total droplets) can be tolerated before 25 % quantification 
bias is reached (Lievens et al., 2016). Hence, we propose the latter as a rule of thumb for the 
maximum amount of rain in a given reaction. A tool to calculate the amount of rain is described in 
Lievens et al., 2016. 
5.4.3 Resolution  
Peak resolution is a concept from the field of HPLC (High Pressure Liquid Chromatography) that 
translates well to dPCR when applied to the density plots of the droplet fluorescence readings. The 
resolution of a digital assay (Rs) is a quantitative measure of how well the two populations (positive 
and negative), hereinafter referred to as peaks, can be differentiated in a linear separation. It is 
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defined as the difference in fluorescence between the two peaks, divided by the combined widths of 
the peaks: 
𝑅𝑠 =  
2 ∗ (𝑡𝑝 − 𝑡𝑛)
𝑤𝑝 + 𝑤𝑛
 (10) 
where the subscript p indicates the population with the higher fluorescence (positive, as opposed to 
n for the negatives). The variables t and w are the peak fluorescence and peak width, respectively 
(Figure 8). 
 
Figure 8: Illustration of the concept of resolution. The left-hand figures show the droplet readout; the right-hand figures 
show the corresponding density plots. tn and tp show the fluorescence positions with the highest density in the negative 
and positive droplet clouds, respectively. wn and wp represent the width of the density peaks at their base (Lievens et al., 
2016). 
Essentially, the resolution corresponds to how well the fluorescence of the droplet populations is 
separated. A resolution of 2 represents a complete separation; we propose 𝑅𝑠 = 2 as a minimum to 
allow for a certain amount of deterioration of the resolution in more difficult samples. At 𝑅𝑠 = 2.5 
there is high resolution and at 𝑅𝑠= 0.5 there is low resolution. 
5.4.4 Target concentration 
As mentioned in several papers (Dube et al., 2008; Jacobs et al., 2014), there is an optimal 
concentration of target molecules per partition that should yield the least random sampling 
variability (and thus the narrowest confidence bounds). This optimal value of λ for absolute 
quantification is approximately 1.6, i.e. if random sampling variation as described by the Poisson 
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process is the only source of variability. For a partition size of 0.85 nl (ddPCR), this translates to an 
optimum of about 1,870 target copies per μl or 37,400 per 20 μl total reaction mix. For a partition 
size of 6 nl (cdPCR), this translates to final concentrations of about 265 copies per μl or 2,650 copies 
per 10 μl total reaction mix for optimal conditions. 
An upper and lower bound for optimal quantification can be found by inspecting the fraction of 
reactions that have more than 25 % error due to Poisson variation (see Lievens et al., 2016 for details 
on the bootstrap approach). Table 1 shows the results for the bootstrap. In addition, the table also 
shows how these limits shift when instead of a single reaction, multiple repeats are used (i.e. 
averaged) to estimate λ. 
Table 1: Results from the bootstrap analysis The table lists the lowest and highest values (as λ and as number of target 
copies per reaction) at which 95 % of all reactions contain less than 25 % error.  
dPCR system 20,000 partitions 765 partitions 
Value λ DNA copies λ DNA copies 
repeats lower upper lower upper lower upper lower upper 
1 0.0030 8.86 61 177,297 0.077 5.51 59 4,218 
2 0.0014 9.51 29 190,270 0.038 5.31 29 4,063 
3 0.0012 9.92 23 198,378 0.030 5.31 23 4,063 
4 0.0011 10.00 21 200,000 0.020 6.53 15 4,993 
 
5.4.5 Amount of sample compartmentalized 
Both droplet and chamber-based dPCR systems are subject to variability in the number of partitions 
that are generated and/or accepted into the analysis. On top of that, most compartmentalization 
techniques have a certain ‘dead volume’. Consequently, and unlike in qPCR, the entire volume of 
sample loaded into the chamber/droplet generator is not analysed. This essentially corresponds to a 
form of subsampling which may in turn add variation or error to the quantification, especially for 
reactions with targets at very low abundance. We can express the number of partitions in the 
analysis in a relative way, i.e. as the fraction of sample compartmentalized: the total volume of 
partitions accepted into the analysis divided by the total volume loaded into the device. 
For droplet-based dPCR, (in silico) simulation results show that there is an increase in variability as 
less of the total sample is compartmentalized (Lievens et al., 2016). However, for endogene λ = 3 and 
1 % analyte, one can go down to very low levels of compartmentalisation (< 10 %) before the chance 
of excessive error (> 25 %) becomes greater than 1 in 20 (i.e. 95 % of the simulations have less than 
25 % relative error). For lower levels of analyte, a higher compartmentalisation level is required to 
keep 95 % of the simulations below 25 % error, and the same is true for lower values of λ. From these 
results, we propose to require at least 30 % compartmentalisation for quantification down to 1 %, 
and 50 % compartmentalisation for quantification down to 0.5 %. Runs with lower 
compartmentalisation should therefore be omitted. 
5.4.6 Unit of measurement 
The GM content measured by dPCR is expressed as a copy number ratio but does not provide an 
estimate of the amount of GM in mass fraction as required by the EU legislation. The conversion of 
copy number ratio into mass fraction can be done via one single conversion factor (CF) per event. A 
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recent guidance document explains how to report traceable and comparable results expressing GM 
content in accordance with EU legislation (Corbisier et al., 2017).  
5.5 Data interpretation and reporting  
5.5.1 Data interpretation  
As far as data interpretation is concerned, a dedicated ENGL Working Group on "Detection, 
Interpretation and Reporting on the presence of authorised and unauthorised genetically modified 
materials" (WG DIR) has been established in order to amend and update the previously produced 
document on "The detection, interpretation and reporting on the presence of unauthorised 
genetically modified materials" (Ciabatti et al., 2017). This document is designed: 
 To help laboratories to take the appropriate decisions on compliance on the basis of the 
results obtained and the requirements of the EU legislation on GM food and feed currently 
in place; 
 To provide all the relevant data and information on analytical reports according to the 
obligations of the EU legislation on GM food and feed and ISO standards. 
 
Even though the previous document is non-exhaustive, it addresses the most frequent cases and 
should be considered as a source of guidance on the matter. It applies to the official analytical 
control of the following GM events for the enforcement of EU legislation on GM food and feed. Some 
particular cases may require further adaptive interpretation. Future developments and/or legal 
requirements (e.g. new tolerance or labelling thresholds, etc.) should be taken into consideration in 
case of future amendments to the document. 
 GM events authorised on the EU market for food and feed: for traceability and labelling 
requirements, the laboratory is requested to verify the presence of these events above a 
0.9 %-threshold; 
 GM events unauthorised or withdrawn from the EU market, which are falling under the 
scope of Reg. (EU) 619/2011: the laboratory is requested to verify the presence of these GM 
events taking into consideration the Minimum Required Performance Limit (MRPL) set by the 
Regulation at 0.1 %. A technical guidance document on the implementation of Commission 
Regulation (EU) 619/2011 has been developed and published by the EURL GMFF (Mazzara et 
al., 2011); 
 GM events unauthorised or withdrawn from the EU market, to which a Commission 
Implementing Decision on the withdrawal from the market and on a tolerance period for 
traces applies. The laboratory is requested to verify the presence of these GM events taking 
into consideration the MRPL of 0.1 %. For GM events currently fulfilling the requirements of 
Reg. (EC) No. 619/2011 as well as for information about specific validated detection methods 
and the source of certified reference material please refer to: 
http://ec.europa.eu/food/dyna/gm_register/index_en.cfm. 
 GM events unauthorised or withdrawn from the EU market, which are not falling under the 
scope of Reg. (EU) 619/2011 and to which no Commission Implementing Decision on the 
withdrawal from the market and on a tolerance period for traces applies: the laboratory is 
requested to verify the presence of these GM events without any tolerance threshold or any 
MRPL. 
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The WG DIR document does not address the official analytical control of seeds, for which no 
traceability/labelling threshold or MRPL has yet been established in the EU. However, the reporting 
requirements are also applicable to seed testing. 
A decision tree has been presented by the group and refers to the following stepwise analytical work 
flow, which is generally adopted by laboratories to verify the enforcement of EU legislation on GM 
food and feed: 
1. Detection of the ingredient/component/constituent of the food/feed: this is performed using 
taxon-specific methods; 
2. GMO screening: this is usually performed using element and/or construct-specific methods; 
3. GM event identification using qualitative event-specific methods; 
4. GM event quantification using quantitative event-specific methods. 
However, there may be specific cases where one or more of the steps listed above are not necessary 
or useful and may be skipped. For unauthorised GMOs (UGMs), step 3 and 4 will often not be 
possible because of the lack of event-specific detection methods and/or reference materials. Zero 
tolerance of UGMs in food is prescribed in the EU (Figure 9). 
 
 
Figure 9. Decision tree for GMO analysis (Figure based on Ciabatti et al., 2017). 
# The term "inconclusive" is used in this context with the meaning that, if a taxon is not detected, the analytical request to 
detect and identify possible GM events for this taxon cannot be satisfied. 
## The term "donor organism-specific test" means to test for the presence of organisms in which the screening elements 
are naturally present. 
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* 0.1 % Minimum Required Performance Limit applies to methods for the detection of GM events falling under the scope of 
Regulation (EU) No 619/2011 
** A tolerance threshold applies to some products according to specific Commission Implementing Decisions on their 
withdrawal from the market: e.g. Commission Implementing Decision (EU) 2016/2268 of 14 December 2016 amending 
Decisions 2007/305/EC, 2007/306/EC and 2007/307/EC as regards the tolerance period for traces of Ms1xRf1 (ACS-BNØØ4-
7xACS-BNØØ1-4) hybrid oilseed rape, Ms1xRf2 (ACS-BNØØ4-7xACS-BNØØ2-5) hybrid oilseed rape and Topas 19/2 (ACS-
BNØØ7-1) oilseed rape, as well as of their derived products; it sets a 0.1 % tolerance threshold until 31 December 2019. 
*** provided that this presence is adventitious or technically unavoidable  
Results should be reported according to ISO 24276/Amd1:2013, ISO 21569/Amd1:2013 and ISO 
21570/Amd1:2013 
5.6 Digital MIQE guidelines 
The growth of interest in dPCR, both as an aid in metrological traceability and as a real-life 
application across a range of sectors including food testing, means that a plethora of data is being 
produced. This has led to the establishment of a set of guidelines for the production and publication 
of dPCR data, in order to harmonise the approach and provide meaningful results which can be 
readily interpreted (dMIQE guidelines, Huggett et al., 2013). Methods based on dPCR can be applied 
in various areas of food analysis. The methodology is a quantitative technology by nature, but it can 
be used for screening purposes as well. 
The original qMIQE guidelines (Minimum Information for Publication of Quantitative PCR 
Experiments; Bustin et al., 2009) were published with the aim of improving qPCR analyses and 
ensuring data comparability and reproducibility. These were rapidly adopted by a number of 
stakeholders as a useful way in striving towards harmonisation of qPCR results. 
Shortly after this in 2013, the digital MIQE guidelines (dMIQE; Minimum Information for Publication 
of Quantitative Digital PCR Experiments guidelines; Huggett et al., 2013) were published, in order to 
help harmonise results from dPCR experiments. The dMIQE guidelines provide a checklist of items to 
address when publishing results from dPCR experiments to help ensure that results can be 
reproduced, followed and understood. The aim of the dMIQE guidelines is three-fold: i) to facilitate 
replication of experiments; ii) to provide critical information to allow analysts and reviewers to 
measure the technical quality of work; iii) to help towards harmonisation of reporting of 
results/comparison of results irrespective of dPCR instrumentation used. 
The items in the dMIQE guidelines checklist are categorised as either essential (E) or desirable (D) to 
report when publishing results. 
Essential (E) information to report includes, but is not limited to: 
 Mean DNA target copies per partition (lambda); 
 Number of partitions used (lambda and the partition number determine the precision 
associated with the experiment); 
 Template structural information – there is evidence to suggest that the nature of the sample 
can affect the reliability and accuracy of the result. It is important to capture aspects of the 
structural information of the template, including: template type (e.g. genomic, plasmid); 
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source (e.g. organism, tissue, cell, flour, food, plant, leaf); treatment (e.g. restriction 
digestion, sonication, pre-amplification, none); 
 Individual partition volume – different dPCR platforms have different partition volumes2;  
 Total volume of reaction = (number of partitions) x (partition volume). This is particularly 
important for ddPCR as total volume can differ between runs because of variability in 
number of partitions generated; 
 Nature of controls used; 
 Supplemental data – representative amplification plots (or endpoint fluorescence values) of 
positive and negative experimental results; 
 Example experimental variance – the analyst is encouraged to take multiple biological 
replicates to more accurately capture the experimental uncertainty. 
Desirable (D) information to report includes, but is not limited to: 
 Optimisation data for the assay; 
 Total initial PCR reaction volume prepared – not all instruments use the total volume and 
sample volume may be much smaller; 
 LOD of assay. 
It is a recommendation of this WG that the essential items outlined in the dMIQE guidelines should 
be documented when publishing dPCR experimental results, as an aid to harmonised presentation of 
results from analysis of GMOs using dPCR instrumentation. 
6. Costs and practicability of dPCR 
Assuming that all currently active GMO laboratories already possess qPCR equipment, the laboratory 
may benefit from performing a cost-benefit calculation prior to investing in dPCR equipment.  
6.1 Instruments costs 
Currently two types of technology are applied to create reaction partitions. One is based on specially 
designed chips or plates (Fluidigm, Formulatrix or Applied Biosystems) and the other sequester 
reagents into individual droplets (Bio-Rad, RainDance and Stilla Technologies). Recent advances in 
nanofabrication and nanofluidics enabled building dPCR platforms capable of generating thousand or 
even millions of PCR partitions. The final costs of analysing each sample will depend greatly on the 
platform, price of consumables and the time required to set up and analyse samples. 
6.2 Consumables cost 
The price for consumables as well as for instruments can vary depending on the producer’s pricing 
policy for a particular market. Digital PCR uses the same reagents (primers and probes) as qPCR but 
specific consumables (chips, cartridges, gaskets, holders, pipettes etc.) are required for each 
instrument. For ddPCR, the QX 100/200 ddPCR system from Bio-Rad can generate up to 20,000 
droplets (usually 14,000–18,000) per sample on an 8-sample cartridge. Up to 96 samples can be 
analysed at once assuming samples from 12 cartridges are transferred into a 96-well PCR plate and 
run together. The Naica System is based on chips that can be used for four samples. Each sample is 
distributed into approximately 30,000 individual droplets, where a maximum of three chips can be 
run simultaneously. RainDrop Digital PCR can generate up to 10,000,000 droplets per sample and run 
                                                          
2
 also see Vynck and Thas, 2018 
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8 samples per chip. For cdPCR, Fluidigm offers partition of samples into 765 chambers in each of the 
12-chip panels (765 chambers x 12 panels = 9,180 reactions per chip), or a chip with 48 arrays (770 
chambers per array) capable of producing 36,960 individual PCRs simultaneously. The QuantStudio 
3D uses one chip per sample, where the reaction mixture is distributed into 20,000 wells present in a 
chip. Twenty-four chips can then be run together in a PCR cycler, but each chip needs to be read 
individually. The Constellation system from Formulatrix offers plates where 96 samples can be loaded 
and each is distributed into 8,000 chambers or 24 samples can be loaded and each is distributed into 
36,000 chambers. 
6.3 Practicability 
Each dPCR platform has some advantages and limitations in terms of using it in practice. There are 
also some bespoke procedures to learn in order to generate the required number of droplets or fully 
load the chip. Some systems enable analysis of the full kinetics of the amplification per partition 
(BioMark HD, QuantStudio 12K Flex), whilst others are built to detect end-point amplification only 
(Bio-Rad QX100, QX200, RainDrop Digital PCR, Naica System, QuantStudio 3D, Constellation).  
When comparing qPCR and dPCR in terms of costs, some producers of dPCR platforms advertise the 
systems on the basis of very low costs for a single data point. This price can be very small especially 
in systems capable of generating millions of partitions. However, the instrument should be tailored 
to each application which may require a large number of 'single data points' to generate a 
meaningful result. For instance, two hundred chambers are sufficient to distinguish between 2 and 3 
copies in a sample, but at least 8,000 partitions are required to distinguish between 10 and 11 copies. 
Systems generating millions of partitions are capable of detecting very rare mutations or quantifying 
very low concentrations of DNA copies, as with more partitions a higher dynamic range can be 
achieved.  
It is therefore difficult to estimate the exact costs of using dPCR in routine testing or research as the 
total price will depend on several factors. Each user should estimate the costs of dPCR in particular 
applications taking into account: 
 The price of the instrument and costs of maintenance; 
 Costs of consumables and reagents; 
 The achievable throughput of the system; 
 Ease of use of the system; 
 Required precision and sensitivity; 
 Possibility of multiplexing; 
 Additional capacity of performing qPCR; 
 Hands-on time; 
 Sample throughput per runtime; 
 Analysis time. 
 
The costs for analysing a sample with dPCR and qPCR can be comparable or deviate strongly 
depending on the different platforms that are compared. This comparison only makes sense within a 
particular market which is being considered (and not between different/deviating markets). The 
aspect of hands-on-time for analysis and the complexity of handling are crucial parameters that need 
to be considered. 
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The qPCR technology has been present on the market for around two decades. As a result, it is well 
established in many testing and research labs. It has higher throughput and for many routine 
applications it also costs less. Digital PCR can offer more precision and less uncertainty than qPCR, 
however, it offers a narrower dynamic range. Some dPCR systems that require less hands-on time 
will probably find more application in routine testing, especially in medical diagnostics where 
reproducibility is of great importance. Other systems that offer more flexibility might become the 
system of choice in research labs. 
In case of GMO quantification, dPCR offers similar performance as qPCR but in some cases can 
outperform qPCR in terms of cost-effectiveness. The possibility of multiplex quantification of GM 
events of the same species is a good example of reduced hands on time and costs compared to qPCR 
quantification. A method for direct quantification of twelve approved GM maize lines with multiplex 
assays with ddPCR recently (Dobnik et al., 2015) proved to be cost-efficient particularly for testing 
higher number of samples. Direct quantification of twelve approved GM maize lines with 4-plex and 
10-plex multiplex assays with ddPCR compared to direct quantification of twelve approved GM maize 
lines in simplex reactions with qPCR proved to be 3 times cheaper and can save six working days until 
the result is obtained (the case of analysing 11 samples). For labs testing many mixed samples, the 
most cost efficient approach could be combining qPCR screening of all samples prior to multiplex 
ddPCR quantification of the screening positive samples. Developed ddPCR multiplex maize assays can 
provide more cost-effective GMO quantification, especially when the system is extended to include 
additional species relevant GM events. In case of quantification of various targets as one group, dPCR 
offers high flexibility of multiplexing and can easily be applied to diverse testing fields. 
6.4 In-house verification  
For the in-house verification of dPCR methods (based on validated qPCR methods which are to be 
transferred to a dPCR format), several parameters associated with quantification should be 
inspected. Analogous to qPCR, these parameters are: specificity, trueness (when possible), 
repeatability, robustness, and LOD/LOQ (Hougs et al., 2017). The variability associated with the 
repeatability, intermediate precision and bias can be used to estimate the measurement uncertainty 
of a dPCR result. The general principles provided in the technical report from Trapmann et al. (2009) 
to estimate the analytical variability of quantitative analytical results obtained by real-time PCR can 
also be applied for dPCR methods. The approach detailed below to determine the uncertainty 
associated to a dPCR result is using data derived from within-laboratory samples (ISO 5725-2; 
Linsinger, 2008). 
6.4.1 Specificity 
The dPCR method does not differ in its concept from qPCR. The principle of amplification of DNA 
target molecules is the same as for qPCR. The specificity of a PCR assay is provided by the use of 
high-fidelity polymerase and an appropriate primers/probe design (DNA sequences). If the 
specificity of a method has been demonstrated in qPCR, the sequence of the primers/probe as well 
as the reaction conditions should be maintained in a dPCR format. Changes may have to be made to 
optimise dPCR (e.g. by altering MgCl2 concentration of the PCR reaction buffer, by changing the 
annealing temperature, the primer and probe concentrations or the ramping setting). Depending on 
the changes made to the method (e.g. master mix, thermal program, etc.) a re-evaluation of the 
method's specificity may be necessary (see 4.3 and annex B.3 for details).  
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6.4.2 Repeatability  
Repeatability is the precision under a set of repeatability conditions that includes the same 
measurement procedure, same operators, same measuring system (method and dPCR device), same 
operating conditions and same location and replicate measurements on the same or similar samples 
over a short period of time. To estimate the repeatability, one can use for example two samples, a 
high concentration (e.g. 10 % GM material) and a low concentration (e.g. 1 % material), which are 
analysed in triplicates across five different days. The results are then inspected for their variability 
over the different days, e.g. by a one-way ANOVA (Analysis of Variance), an example of which is 
given below.  
With the three replicates over the five days there are five estimates of the variance. The MSw (within 
Mean Square) captures the variability within each different day. The relative repeatability standard 
deviation (RSDr) is given by equation 11: 
𝑅𝑆𝐷𝑟 =  
√𝑀𝑆𝑤
?̅?
 (11) 
 
where ?̅? is the overall mean estimate, and MSw is the within Mean Square expressing the variance 
observed within a day. 
6.4.3 Intermediate precision 
The Intermediate precision reflects the precision over time (for example between days). The relative 
between-day standard deviation 𝑅𝑆𝐷𝑖𝑝 is given by equation 12: 
𝑅𝑆𝐷𝑖𝑝 =  
√
𝑀𝑆𝑏−𝑀𝑆𝑤
𝑛
?̅?
 
(12) 
where 𝑀𝑆𝑏 is the between group variance capturing the variability between each days, 𝑀𝑆𝑤 is the 
within Mean Square capturing the variance observed within a day, 𝑛 is the number of replicates per 
day and ?̅? is the overall mean estimate. 
When MSw is bigger than MSb the maximum hidden between-day-variation (s*ip) can be calculated 
with equation 13: 
𝑠𝑖𝑝
∗ =  √
𝑀𝑆𝑤  
𝑛
 ∗  √
2
𝑝 (𝑛 − 1)
4
 (13) 
where, 𝑀𝑆𝑤 is the within Mean Square capturing the variance observed within a day, 𝑛 the number 
of replicates per day and 𝑝 the number of days.  
The relative standard deviation for intermediate precision (𝑅𝑆𝐷𝑖𝑝) is then obtained by dividing 𝑠𝑖𝑝
∗
 
by the overall mean estimate ?̅? (equation 14). 
𝑅𝑆𝐷𝑖𝑝 =  
𝑠𝑖𝑝
∗
?̅?
 (14) 
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Note: In this example, the experiment is repeated on different days to capture the day-to-day 
variation, however it also possible to perform several runs on one single day to cover all factors that 
may contribute to the uncertainty of the measurement. 
 
6.4.4 Standard relative uncertainty related to precision 
From the above, one can calculate the relative standard uncertainty related to the precision within 
one laboratory by combining the relative standard deviations associated with repeatability and 
intermediate precision, as shown in equation 15: 
𝑢𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛,𝑟𝑒𝑙 = √
𝑅𝑆𝐷𝑟
2
𝑛 ×  𝑝
+  
𝑅𝑆𝐷𝑖𝑝
2
𝑝
 (15) 
where 𝑢𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛,𝑟𝑒𝑙  is the relative standard uncertainty related to the precision, RSDr the relative 
repeatability standard deviation, 𝑅𝑆𝐷𝑖𝑝 the relative standard deviation for intermediate precision, 𝑝 
the number of days and 𝑛 the number of replicates per day. 
Note: The uncertainty related to the conversion of the number of positive droplets into copy number 
concentration varies very much in relation to the lambda value. The lowest uncertainty is observed 
for a lambda around 1.6 (Lievens et al., 2016). This means that the solution with the extracted DNA 
for the endogen assay needs to be diluted before being added to the master mix, whereas in most 
cases the DNA of the transgene does not need to be diluted.  
6.4.5 Trueness  
Definition: Closeness of agreement between the average value of an infinite number of replicate 
measured quantity values and a reference quantity value. The measure of trueness is usually 
expressed in terms of bias (ISO/IEC Guide 99:2007). The bias is the difference between the 
expectation of the test results and an accepted reference value (ISO 5725-1:1994). The absence of 
significant bias should be tested over the whole dynamic range of the method. 
Note: An accepted reference value is a value that serves as an agreed-upon reference for 
comparison, and which derives from: 
 
a)  a theoretical or established value, based on scientific principles; 
b) an assigned or certified value, based on experimental work of a national or international 
organisation; 
c) a consensus or certified value, based on collaborative experimental work under the auspices 
of a scientific group; 
d) the expectation of the (measurable) quantity, i.e. the mean of a specified population of 
measurements  when a), b), c) are not available. 
 
The trueness of a result obtained by dPCR can be assessed by comparing the average measured value 
of a CRM with its certified value. The CRM should be a material certified for its absolute copy number 
concentration or a material certified for its copy number concentration ratio. The bias between the 
measured concentration (𝐶𝑜𝑛𝑐𝑚) and the certified copy number concentration (𝐶𝑜𝑛𝑐𝑐) is provided in 
equation 16.  
𝑏𝑖𝑎𝑠 =  |𝐶𝑜𝑛𝑐𝑚 − 𝐶𝑜𝑛𝑐𝑐| 
(16) 
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The uncertainty associated with this bias can be calculated as followed: 
𝑢𝑏𝑖𝑎𝑠 = √𝑢𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛
2 + 𝑢𝐶𝑅𝑀
2   
(17) 
where 𝑢𝐶𝑅𝑀 is the uncertainty of the certified value obtained by dividing the expanded uncertainty 
(𝑈𝐶𝑅𝑀) by a coverage factor k, both found on the certificate of the CRM. The standard uncertainty 
related to precision (𝑢𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛) is calculated when the relative standard uncertainty related to 
precision (𝑢𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛,𝑟𝑒𝑙) – provided by equation 15 – is multiplied by the mean value (?̅?) obtained 
when analysing the CRM. 
𝑢𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 = 𝑢𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛,𝑟𝑒𝑙 ∗ ?̅? (18) 
The expanded uncertainty 𝑈𝑏𝑖𝑎𝑠 is estimated by multiplying the standard uncertainty associated to 
the bias 𝑢𝑏𝑖𝑎𝑠 by a coverage factor k = 2, providing a level of confidence of approximatively 95 %. 
𝑈𝑏𝑖𝑎𝑠 = 2 ∗ 𝑢𝑏𝑖𝑎𝑠 
(19) 
Acceptance criterion: A bias will be significant if it is larger than the expanded uncertainty of the 
difference between result and certified value (𝑈𝑏𝑖𝑎𝑠) [ERM application note 1, 2010]. If a significant 
bias is observed, either the origin of the bias should be further investigated (e.g. through 
improvement of the dPCR method) or the results should be corrected for that bias. 
6.4.6 Uncertainty estimation 
The relative uncertainty of a measurement result (𝑢𝑚𝑒𝑎𝑠,𝑟𝑒𝑙) can be estimated by combining the 
relative uncertainty associated with the precision (𝑢𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛,𝑟𝑒𝑙) with the relative uncertainty 
associated with the trueness (𝑢𝑏𝑖𝑎𝑠,𝑟𝑒𝑙). The uncertainty of the bias is included in the uncertainty 
budget regardless of whether or not the bias was found to be significant (Linsinger et al., 2008). 
 𝑢𝑚𝑒𝑎𝑠,𝑟𝑒𝑙 =  √𝑢𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛,𝑟𝑒𝑙
2 + 𝑢𝑏𝑖𝑎𝑠,𝑟𝑒𝑙
2   (20) 
𝑢𝑏𝑖𝑎𝑠,𝑟𝑒𝑙  is obtained by dividing 𝑢𝑏𝑖𝑎𝑠 (Eq. 17) by the mean value measured on the CRM. 
 
Note: The relative standard uncertainty for calculating uncertainty estimates can be used when the 
percent coefficient of variation is approximately constant over a substantial portion of the measuring 
range (in our case between 1 % and 10 % GM material). 
General note:  𝑢𝑥,𝑟𝑒𝑙 =
𝑢𝑥
?̅?
      or    𝑢𝑥 = 𝑢𝑥,𝑟𝑒𝑙 ∗ ?̅? 
where ux,rel is the relative standard uncertainty, ux is the standard uncertainty and ?̅? the mean value. 
The standard uncertainty is expressed in the unit of measurement (e.g. in g/kg, GM % or DNA copy 
number ratio). The relative standard uncertainty is expressed as a percentage relative to the mean 
value. 
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6.4.7 Limit of Detection (LOD), Limit of Quantification (LOQ) 
The limit of detection (LOD) is the lowest amount or concentration of analyte (e.g. DNA) in a sample 
which can be detected – but not necessarily quantified – based on a given probability. 
Experimentally, methods should detect the presence of the analyte for at least 95 % of the cases 
(samples) at the LOD, ensuring ≤ 5 % false negative results. Analogous to qPCR, the LOD can be 
established in dPCR by measuring successive dilutions of the analyte in replicate measurements.  
The measurement principle of the dPCR makes it possible to detect down to one copy of a target 
sequence and the Poison distribution is applicable at these very low copy number concentrations. 
Therefore, it is reasonable to assess the LOD (and LOQ) by performing many replicate measurements 
at very low copy number concentrations. The assessment should start by clearly defining the level of 
confidence appropriate for the intended use of the method. When performing an experiment e.g. 
with 60 replicate measurements (Marchesi et al., 2015) exactly at the LOD with a confidence interval 
of 95 % there would be on average three negative measurement results, as this represents 5 % of the 
cases. If all of the 60 replicate measurements performed at a certain PCR copy number concentration 
are positive, it can be reasonably assumed that this concentration is above the LOD of the method 
(Deprez et al. 2016). As this approach may not always be feasible, a pragmatic approach based on a 
lower number of replicate measurements could be followed for the verification of the LOD. This 
approach allows an approximate estimation of the LOD. Dilution series representing the range above 
and below the expected LOD, based on prior knowledge of the LOD of that method (e.g. from 
validation data), are tested in e.g. a minimum of 10 PCR replicate measurements for each 
concentration level. The lowest concentration where all replicate measurements are positive is the 
estimated LOD (Hougs et al., 2017). The use of a different approach should be supported by sound 
statistical evidence ensuring that the level of confidence required is reached (Marchesi et al., 2015). 
 
The LOD (and the LOQ) of a dPCR method depend on the number of analysed partitions and the total 
volume of the analysed partitions. It is therefore possible to calculate the theoretical minimum LOD 
for a given dPCR set-up based on the Poisson distribution. The calculation is based on the 
combination of two probabilities: the probability of pipetting the DNA copies in the mix (sampling) 
and the probability that these DNA copies end up in the droplets. In the case of a ddPCR with e.g. 
17,000 analysed (accepted) droplets with an assumed droplet volume of 0.85 nL (also see note of 
table A. 1b in the annex), the minimum theoretical LOD will be 0.29 cp/µL in the PCR mix. At this 
concentration level, 5 % of the measurements will not have a single copy of the target sequence in 
the analysed droplets.  
The Limit of quantification (LOQ) is the lowest amount or concentration of analyte in a sample that 
can be reliably quantified with an acceptable level of trueness and precision. This means that the LOQ 
of a dPCR method depends on the level of uncertainty considered acceptable given the intended use 
of the method. Practically, the LOQ of a dPCR method can be established by measuring the relative 
uncertainty of a measurement result (𝑢𝑚𝑒𝑎𝑠,𝑟𝑒𝑙) at a low copy number concentration or ratio. 
For some dPCR platforms, the manufacturer may give indications about the lower bound of the 
number of partitions needed for accurate quantification.  
6.4.8 Robustness 
The robustness of a method is a measure of its capacity to remain unaffected by small, but deliberate 
deviations from the experimental conditions described in the procedure. 
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Acceptance criterion: the method should provide the expected results when small deviations are 
introduced from the experimental conditions described in the procedure. 
For quantitative modules, based on the acceptance criterion of ≤ 25 % for the relative repeatability 
standard deviation (RSDr) and trueness, the RSDr and trueness calculated for a combination of 
changes should not exceed 30 % (Marchesi et al., 2015). 
Examples of factors that a robustness test should address are experiments performed by another 
operator, different primer and probe concentrations, different annealing temperatures, different 
thermal cyclers, different reaction volumes, and different master mix suppliers (for examples on how 
to assess robustness see e.g. Marchesi et al., 2015; Hougs et al., 2017). 
6.5 Accreditation 
A dPCR method can be submitted for accreditation under ISO 17025. The process of submission 
strongly depends on the scope of the accreditation. Before submission, it is advised that the national 
accreditation body is consulted regarding the dPCR method submission. Digital PCR is essentially just 
a variation of PCR, using the same primers/probes (and in some cases master mix) as qPCR. 
Documents for method submission should be prepared in accordance with a quality system. If a 
laboratory has a scope for PCR based methods, general documents could just be complemented with 
description of dPCR and new documents relating to the dPCR procedures should be prepared. A dPCR 
method must fulfil the above-mentioned verification criteria, if the assays were transferred from 
qPCR to dPCR. New methods should be validated, and pass all of the acceptance criteria if they are to 
be considered for accreditation. 
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Annex 
A. Application of dPCR in the field of GMO detection and quantification – 
explanations, notes and examples  
A. 1 Flow diagram/decision tree for application of (multiplex) event-specific screening methods for 
GMO detection 
 
Event-specific (multiplex) screening approaches (see main text for examples from literature) can be 
used to reach preliminary or conclusive decisions. Positive and negative refers to signal detected and 
signal not detected. Further testing refers to optional use of e.g. singleplex event-specific methods 
for identification and/or quantitation. Relevant events refer to events covered by the scope of the 
test, e.g. in the case of a soybean product it could be: 1) all EU-authorised soybean events in case of 
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testing for compliance with the authorization and labelling regulations 1829/2003 and 1830/2003; or 
2) all soybean events under LLP regulation in the EU in case of testing for compliance with Regulation 
EC 619/2011, respectively. Legally compliant and non-compliant refers to cases where the product is 
or is not compliant with the legal requirements in e.g. one of the mentioned regulations. Certainly 
above or below a legal threshold refers to the inferred concentration/value after taking the 
associated measurement uncertainty into account. 
A. 2 Lambda optimised approach  
The dynamic range of a dPCR may cover four to six orders of magnitude, approaching those of qPCR 
(up to seven orders of magnitude), depending on the partition number of the dPCR device used 
(RainDance Technologies device; Jones et al., 2016). It should be mentioned that some 
devices/analysis tools allow several wells to be merged in order to increase the number of partitions 
analysed and thus to increase the dynamic range. However, as described for chamber dPCR (BioMark 
device; Bhat et al., 2009) or droplet dPCR (Bio-Rad device; Pinheiro et al., 2012; Deprez et al., 2016), 
the relative uncertainty of the determined concentration is not constant across the dynamic range. 
The stochastic effect (i.e. impact on measurement uncertainty) associated with the (sub-)sampling 
(* see note) of a DNA solution increases as the concentration of the DNA solution decreases. It is 
advisable for dPCR to check the copy numbers of a DNA solution in a test run in order to determine 
reference and transgene copy numbers. Alternatively, multiple dilutions of DNA can be analysed 
simultaneously. For samples with low GM content (** see note), i.e. where a low number of 
transgenic copies are present among a high number of copies of species reference gene, it is advised 
to use at least two different DNA dilutions.  
DNA copy number concentration adjustments can be achieved by testing the DNA extracts at two 
dilutions, one optimised dilution for the reference gene reaction and one optimised dilution for the 
transgene reaction. This optimisation avoids having either too many negative or positive partitions 
for both transgenic and reference gene reaction. 
The DNA copy number determination can be done either by simplex or by duplex dPCR, depending 
on the laboratories´ preference. The result is then determined by combining the results of the two 
"lambda optimised" reactions taking the dilution factors of the DNA solutions used into account.  
* Note: The term ´sampling´ refers to the fact that not the entire PCR reaction (including the DNA 
molecules) is read in the droplet reader (´dead volume´). 
** Note: For the present Bio-Rad System (QX100 or QX200) low transgenic DNA copy numbers would 
correspond to approximately 0.1 %. For other devices, it could be higher or lower depending on the 
number of partitions used. 
Example for a ddPCR device with a maximum of 20,000 droplets generated:  
A maize sample containing 0.1 % (m/m) of MON 810 (hemizygous for the transgene), that sample – 
assuming a conversion factor (zygosity) of 0.5 – contains 2,000 times more species specific DNA 
copies (hmg) than MON 810 transgene copies. Considering a DNA solution (with 5 µL of that solution 
in a total dPCR volume of 22 µL) containing 8,282 copies (*** see note) of hmg per µL DNA solution 
and (theoretically) more than 4 copies of MON 810 (2,000 times less). The lambda value (λ = number 
of DNA copies per droplet in a ddPCR, see 4.1) for the hmg reaction will be close to 1.6. At this 
lambda value, the conversion of positive droplets into copies has the lowest variability and the 
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dilution applied to the DNA extract is indeed optimal for that hmg reaction. However, the lambda 
value for the MON 810 reaction in this diluted DNA sample will be below 0.001 (Table A 1a, No 1), 
which is not optimal considering the error due to Poisson variation (Lievens et al., 2016). When, for 
example, measuring a few transgene DNA copies less, the result (GMO percentage) will substantially 
change (Table A 1a, No 2). When scaling up the DNA quantity (e.g. roughly three or six times) used in 
PCR, lambda for MON 810 can be improved (Table A 1a, No 3 and 4). The lambda optimised ddPCR 
results can then be combined (Table A 1b, No 5 and 6). 
Table A 1a. Lambda values in ddPCR for a 0.1 % (m/m) heterozygous gm maize material at different DNA sample 
concentrations 
 
No 
 
ddPCR 
+ d total d 
estimated 
cp in 
total d *** 
λ 
[cp/d] 
DNA 
diluted 
 sample 
 [cp/µL] 
*** 
Ratio 
cp/cp 
[%] 
Ratio 
m/m 
[%] a) 
DNA 
dilution 
factor 
1 
hmg 13,568 17,000 27,200 1.6001 8,282 
0.051 0.103 6.0 
MON 810 14 17,000 14 0.0008 4.26 
2 
hmg 13,568 17,000 27,200 1.6001 8,282 
0.033 0.066 6.0 
MON 810 9 17,000 9 0.0005 2.74 
3 
hmg 16,869 17,000 82,716 4.8658 25,187 
0.048 0.097 2.0 
MON 810 40 17,000 40 0.0024 12.19 
4 
hmg 16,999 17,000 165,592 9.7410 50,422 
0.048 0.097 1.0 
MON 810 80 17,000 80 0.0047 24.42 
 
+ d: positive droplets 
cp: DNA copy number 
total d: total measured (accepted) droplets 
λ = number of estimated DNA copies per droplet [cp/d]  
a)
: a conversion factor (CF) of 0.5 was assumed to convert cp/cp [%] into m/m [%] 
 
Table A 1b. Combination of lambda optimised ddPCR results taking different dilution factors into account 
 
No 
 
ddPCR 
+ d total d 
estimated 
cp in 
total d  
*** 
λ 
[cp/d] 
DNA 
diluted 
sample 
 [cp/µL] 
*** 
DNA 
not 
diluted 
cp/µL 
*** 
Ratio 
m/m 
[%] a) 
DNA 
dilution 
factor 
5 
hmg 13,568 17,000 27,200 1.6001 8,282 49,695 
0.097 6.0 
MON 810 40 17,000 40 0.0024 12.19 24.39 2.0 
6 
hmg 13,568 17,000 27,200 1.6001 8,282 49,695 0.097 6.0 
MON 810 80 17,000 80 0.0047 24.42 24.42 1.0 
 
*** Note: The average droplet volume was assumed to be 0.85 nL according to Bio-Rad software 
QuantaSoft (from version 1.6.6.0320 onwards). There is strong evidence that the average droplet 
volume is actually smaller, ranging from 0.837 nL (Dong et al., 2015) and 0.834 nL (Corbisier et al., 
2015) to 0.718 nL (Košir et al., 2017b), the latter volume depending on the cartridges, droplet 
generator and master mix used. The (assumed) droplet volume has an impact on the calculation of 
absolute copy number concentration only. For the determination of a copy number ratio, the 
average droplet volume has no influence on the calculation results. 
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In such a case, where low DNA copies (e.g. transgene) are to be quantified, the measurement of two 
different dilutions of the DNA extract should be considered. In the above mentioned (theoretical) 
example the DNA extract was diluted to optimize the hmg reaction (lambda = 1.6). A three to six 
times more concentrated — i.e. less diluted — DNA extract (Table A 1a, No 3 and 4) will improve the 
lambda values for the MON 810 reaction (0.0024 and 0.0047, respectively) but will finally saturate 
the hmg reaction (BioRad Bulletin 6407 Rev A; Taylor et al., 2015). In order to optimise the transgenic 
reaction and to reduce uncertainties at low DNA concentration due to positive droplet count 
variation, the number of positive droplets should give the result in copies per reaction above the LOQ 
of a specific method.  
A. 3 Practical aspects of multiplex dPCR  
1. Multiplex PCR with several probes labelled with the same fluorescent dye may increase the 
background fluorescence of the negative droplets reducing the distance between the negative 
cluster and the positive cluster(s) (Dobnik et al., 2015). A reduced discrimination between the 
clusters may increase the chance of droplet misclassification and may make quantification of low 
GM contents more challenging. Therefore optimization and validation of the method is necessary, 
as for any method or approach. 
2. The copy number ratio measured by dPCR needs to be converted into a mass fraction. The applied 
conversion factor (CF) needs to be linked to the calibrant used in qPCR (to obtain comparable and 
traceable results between qPCR and dPCR techniques). A conversion factor is determined for each 
certified reference material (CRM) (Corbisier et al., 2017).  
3. A multiplex approach for heterozygous GM material (e.g. GM maize), which sums up different GM 
contents per species, forces use of a generic species CF which may increase the uncertainty of the 
measurement, if individual CFs deviate significantly from the generic CF. This is particularly 
relevant, when quantification at concentrations around a legal threshold is performed. In such 
cases the performance of individual (singleplex) quantification reactions is recommended. 
B. Technical part specific for the implementation of dPCR in a laboratory 
In this section a summary of technical recommendations, explanations and notes are given, that are 
specific to dPCR. For other issues, such as acceptance criteria for method performance, the same 
requirements apply as for qPCR (Marchesi et al., 2015), if applicable. 
B. 1 dPCR platform verification 
 
B.1.1 DNA copy number determination 
When establishing a new dPCR device in a laboratory, it has to be demonstrated at least once, that 
the laboratory is able to properly use this device and DNA copy numbers can be determined with 
sufficient accuracy in terms of precision and trueness. This is ideally done with reference material 
certified for absolute DNA copy numbers, if available. Alternatively reference material can be used 
that is certified for DNA copy ratio (e.g. ERM®-BF425c , Meyer et al., 2010) or for mass/mass fraction. 
A list of certified reference materials is available e.g. at the JRC 
(https://ec.europa.eu/jrc/sites/jrcsh/files/rm_catalogue_170424.pdf).  
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B. 1.2 Fraction of sample compartmentalised 
There is an increase in variability as less of the total sample is compartmentalized ('dead volume'). 
However, for endogene λ = 3 (lambda, λ is the average number of targets per partition) and 1 % 
analyte, one has to go down to very low levels of compartmentalisation/partitioning (< 10 %) before 
the chance of excessive error (> 25 %) becomes greater than 1 in 20 (i.e. 95 % of the simulations have 
less than 25 % relative error). For lower levels of analyte, more compartmentalisation is required to 
keep 95 % of the simulations below 25 % error, and the same is true for lower values of λ. Based on 
in silico simulations (Lievens et al., 2016) it is proposed to require at least 30 % compartmentalisation 
for quantification down to 1 %, and 50 % compartmentalisation for quantification down to 0.5 %. 
 
Note: Both droplet and chamber-based dPCR systems are subject to variability in the number of 
compartments that are generated and/or accepted into the analysis. Additionally, most 
compartmentalisation techniques have a certain ‘dead volume’. As a consequence, and unlike in 
qPCR, not the entire volume of sample loaded into the chamber/droplet generator is analysed. This 
essentially corresponds to a form of sub-sampling which may in turn add variation or error the 
quantification, especially for reactions with targets at very low abundance.  
 
B.1.3 Dynamic Range 
The dynamic range of the platform should be assessed. This can be done by analysing serial dilution 
of DNA with known DNA content (e.g. Jones et al., 2016). The dynamic range of a dPCR increases, as 
the number of partitions analysed increases. 
B. 2 Method transfer of qPCR methods into a dPCR format 
When a qPCR method is to be transferred into a dPCR format it is recommended to start with the 
examination of the reaction conditions (primer and probe concentrations; temperature profile for 
DNA amplification) as described for the validated qPCR method. Nevertheless this is not always 
possible, e.g. as certain platforms require specific master mixes. 
In case the parameters for dPCR are respected, e.g. single target amplification, amount of rain and 
resolution is acceptable, use the method as such. Otherwise, if the method is to be modified, then 
take into consideration the following parameters and aspects:  
 Annealing temperature 
 Primer and/or probe sequence. In case primer/probe sequence are changed, a full validation 
of such a new method is needed (Marchesi et al., 2015) 
 Use certified reference material (if available) to check for accuracy (trueness and precision), 
ideally certified for DNA copies (range between 10–100,000 per reaction, 6 parallel reactions 
per dilution)  
 If the composition of an alternative master mix is known and comparable to the conditions of 
the validated master mix, then the re-assessment of specificity is not required. Otherwise, an 
experimental check on selected targets (e.g. GM targets and taxa) is recommended 
 
B. 2.1 Peak resolution and intermediate signals in ddPCR 
The conditions for establishing the following parameters should ideally be around λ = 0.7 
(corresponding to 50 % positive and 50 % negative droplets):  
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B. 2.1.1 Minimal peak resolution (𝑹𝒔) 
The resolution of a digital assay (Rs) is a quantitative measure of how well the two populations 
(positive and negative) can be differentiated in a linear separation. It is defined as the difference in 
fluorescence between the two peaks, divided by the combined widths of the peaks: 
𝑅𝑠 =  
2 ∗ (𝑡𝑝 − 𝑡𝑛)
𝑤𝑝 + 𝑤𝑛
 
where the subscript p indicates the population with the higher fluorescence (positive, as opposed to 
n for the negatives). The variables t and w are the peak fluorescence and peak width, respectively. 
 
 Minimal peak resolution (𝑅𝑠) should be at least 2.0, preferably higher than 2.5 
 
B. 2.1.2 Intermediate signals (rain) 
Intermediate signals (rain) may be defined as the compartments whose fluorescence readings are 
between the maximal fluorescence of the negative cluster and the minimal fluorescence of the 
positive cluster. 
 
 Intermediate signals (rain) should be less than 2.5 % of the total number of partitions 
  
B.2.1.3 Threshold setting for analysis 
Threshold setting for classification of partitions as positive or negative should be set just above the 
cluster of negative partitions. Although there is no clear consensus, due to practical experience a 
reaction is usually considered positive, when the number of positive partitions exceeds two (Dobnik 
et al., 2015). 
 
Note: No template control (NTC) samples, generating only negative partitions, can help in setting the 
threshold, however, an inspection of all wells/panels is recommended. The fluorescence amplitude 
of the negatives in individual wells/panels might be slightly higher or lower than NTCs, thus in such 
cases threshold can be adjusted individually to avoid misclassification of droplets. 
B. 3 Optimization of dPCR 
B. 3.1 DNA extraction 
Some DNA extraction methods might interfere with droplet generation. The impact of the extraction 
method on downstream workflow should therefore be evaluated once. This can be done by 
extracting a) a certified reference material, and b) a food sample, with the standard DNA extraction 
methods applied in a specific laboratory. Some extraction method may show significantly deviating 
(poor) performance (e.g. in terms of yield and purity) when applied to certain matrices compared to 
another method. Therefore yield and purity should be checked beforehand and a method should be 
chosen that gives favoured performance with that matrix.  
 
B. 3.2 DNA pre-treatment  
Under certain conditions (e.g. to separate tandem gene copies, to increase random partitioning, to 
reduce sample viscosity of high molecular DNA solutions) pre-treatment of DNA (e.g. with DNA 
dependent restriction endonucleases, 4- or 6-base recognition sites) may be required in order to 
increase accuracy of dPCR measurement. This is to digest the DNA with enzymes (DNA dependent 
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restriction endonucleases, e.g. with 4- or 6-base recognition sites). It should be checked and verified, 
that the enzyme used does not cut the target DNA sequence of interest (i.e. the DNA sequence of the 
PCR generated amplicon). Additionally it is recommended to check the efficacy of digestion step e.g. 
by gel-electrophoresis.  
 
Note: It should be avoided to expose DNA to sustained elevated temperatures or alkaline solution as the 
different strands of fully denatured molecules may be divided across different partitions, leading to two 
positives for a single (double stranded) target copy. As a consequence, if a significant portion of the sample 
DNA is denatured, the amount of target will be overestimated if the user assumes that only double-stranded 
DNA is quantified. 
 
B. 3.3 Target DNA concentration 
There is an optimal concentration of target molecules per partition that should yield the least 
random sampling variability. This optimal value of λ for absolute quantification is approximately 1.6. 
In practice, this value is not always achievable, especially when analysing samples with low target 
DNA concentrations (see Annex A. 1).  
 
B. 3.4 PCR reaction 
• In general, the temperature profile used in qPCR can be directly applied to dPCR. 
However, one should always check the manufacturer's recommendations for specific 
requirements. For example, in droplet-based systems, a final step at higher temperature 
(e.g. 98 °C, 10 min for the Bio-Rad QX100/200 ddPCR systems) may be mandatory to 
further stabilize the droplets prior to detection with the droplet reader.  
• Sometimes it is advisable to run an annealing temperature gradient to find the optimal 
annealing temperature. In case of co-amplification of a secondary target (multiple clouds 
of positive droplets in ddPCR) one can increase the annealing temperature in order to 
generate only one cloud of positive droplets. Lowering the annealing temperature can 
lead to better separation between positive signals and background noise. 
• Primer and probe concentration can be adjusted if necessary. For testing higher and 
lower primer and probe concentration than given in the original qPCR method protocol 
can be used. Higher primer and probe concentrations usually increase the intensity of the 
end-point fluorescence signal and thus allow better separation of the background noise 
from specific signals, aiding more accurate quantification of the target. If deemed 
necessary a primer/probe concentration gradient can be run to improve resolution. 
• Touch down PCR can also be applied to enhance specificity which can lead to less rain. 
Possible conditions for annealing are, e.g. 15 cycle at 63 °C and 15 cycles at 60 °C. 
• Increasing the number of amplification cycles can reduce intermediate signals ("rain" in 
ddPCR), e.g. due to late PCR onset caused by partial inhibition. Suggested total cycle 
numbers are, e.g. 45, 50, 60 or 75).  
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